Omega Healthcare Investors (OHI) 10-Q 8 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	1-May-15
Document and Entity Information [Abstract]
Entity Registrant Name	OMEGA HEALTHCARE INVESTORS INC
Entity Central Index Key	888491
Trading Symbol	ohi
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Entity Common Stock Shares Outstanding		182,683,520
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Real estate properties
Land and buildings	$3,227,983	$3,223,785
Less accumulated depreciation	-847,240	-821,712
Real estate properties - net	2,380,743	2,402,073
Investment in direct financing leases	541,846	539,232
Mortgage notes receivable	649,793	648,079
Real estate properties, total	3,572,382	3,589,384
Other investments	48,268	48,952
Total investments held, continuing operations	3,620,650	3,638,336
Assets held for sale - net	16,877	12,792
Total investments	3,637,527	3,651,128
Cash and cash equivalents	700,143	4,489
Restricted cash	27,880	29,076
Accounts receivable - net	176,877	168,176
Other assets	55,593	68,776
Total assets	4,598,020	3,921,645
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit		85,000
Term loan	200,000	200,000
Secured borrowings	93,719	251,454
Unsecured borrowings - net	2,333,657	1,842,049
Accrued expenses and other liabilities	199,691	141,815
Total liabilities	2,827,067	2,520,318
Stockholders' equity:
Common stock $.10 par value authorized - 350,000 shares, issued and outstanding - 138,752 shares as of March 31, 2015 and 127,606 as of December 31, 2014	13,875	12,761
Common stock - additional paid-in capital	2,580,248	2,136,234
Cumulative net earnings	1,191,050	1,147,998
Cumulative dividends paid	-2,014,220	-1,895,666
Total stockholders' equity	1,770,953	1,401,327
Total liabilities and stockholders' equity	$4,598,020	$3,921,645

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Per Share data, unless otherwise specified
Statement Of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$0.10	$0.10
Common stock, shares authorized	350,000	200,000
Common stock, shares issued	138,752	127,606
Common stock, shares outstanding	138,752	127,606

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS Unaudited (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenue
Rental income	$100,964	$95,918
Income from direct financing leases	14,346	14,084
Mortgage interest income	16,579	9,326
Other investment income - net	1,531	1,673
Total operating revenues	133,420	121,001
Expenses
Depreciation and amortization	30,610	31,444
General and administrative	6,014	6,497
Acquisition costs	4,868	95
Impairment loss on real estate properties	5,982
Provisions for uncollectible mortgages, notes and accounts receivable	-2	-16
Total operating expenses	47,472	38,020
Income before other income and expense	85,948	82,981
Other income (expense)
Interest income	193	8
Interest expense	-32,359	-27,081
Interest - amortization of deferred financing costs	-1,353	-922
Interest - refinancing costs	-9,377	-2,040
Total other expense	-42,896	-30,035
Income before gain on assets sold	43,052	52,946
Gain on assets sold - net		2,883
Net income available to common stockholders	$43,052	$55,829
Basic:
Net income (in dollars per share)	$0.32	$0.45
Diluted:
Net income (in dollars per share)	$0.32	$0.45
Dividends declared per common share (in dollars per share)	$0.89	$0.49
Weighted-average shares outstanding, basic (in shares)	134,346	124,459
Weighted-average shares outstanding, diluted (in shares)	134,806	124,822

CONSOLIDATED_STATEMENT_OF_STOC

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Unaudited (USD $)	Common Stock Par Value	Additional Paid-in Capital	Cumulative Net Earnings	Cumulative Dividends	Total
In Thousands, unless otherwise specified
Balance (127,606 common shares) at Dec. 31, 2014	$12,761	$2,136,234	$1,147,998	($1,895,666)	$1,401,327
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Amortization of restricted stock		1,551			1,551
Vesting of restricted stock to company executives, net of tax withholdings (85 shares)	8	-1,914			-1,906
Dividend reinvestment plan (135 shares at $40.13 per share)	13	5,401			5,414
Grant of stock as payment of directors fees (1 share at an average of $40.61 per share)		50			50
Issuance of common stock (10,925 shares at an average of $40.32 per share)	1,093	438,926			440,019
Net income			43,052		43,052
Common dividends declared ($0.89 per share)				-118,554	-118,554
Balance (138,752 common shares) at Mar. 31, 2015	$13,875	$2,580,248	$1,191,050	($2,014,220)	$1,770,953

CONSOLIDATED_STATEMENT_OF_STOC1

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Unaudited (Parentheticals) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Balance (in shares)	127,606
Vesting of restricted stock, net of tax withholdings (in shares)	85
Shares issued under Dividend Reinvestment and Common Stock Purchase Program	135
Dividend reinvestment plan, shares issued, price per share (in dollars per share)	$40.13
Grant of stock as payment of fees (in shares)	1
Grant of stock as payment of fees (in dollars per share)	$40.61
Issuance of common stock (in shares)	10,925
Issuance of common stock (in dollars per shares)	$40.32
Common dividends, (in dollars per share)	$0.89
Balance (in shares)	138,752

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS Unaudited (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities
Net income	$43,052	$55,829
Adjustment to reconcile net income to cash provided by operating activities:
Depreciation and amortization	30,610	31,444
Provision for impairment on real estate properties	5,982
Provision for uncollectible mortgages, notes and accounts receivable	-2
Amortization of deferred financing and debt extinguishment costs	10,730	2,962
Accretion of direct financing leases	-2,614	-2,350
Stock-based compensation	1,610	2,263
Gain on assets sold - net		-2,883
Amortization of acquired in-place leases - net	-1,192	-1,287
Change in operating assets and liabilities - net of amounts assumed/acquired:
Accounts receivable, net	-196	-431
Straight-line rent receivables	-5,275	-5,324
Lease inducements	-2,110	715
Effective yield receivable on mortgage notes	-1,120	-319
Other operating assets and liabilities	23,819	-2,563
Net cash provided by operating activities	103,294	78,056
Cash flows from investing activities
Acquisition of real estate - net of liabilities assumed and escrows acquired	-6,300	-4,700
Investment in construction in progress	-5,851
Placement of mortgage loans	-2,002	-113,114
Proceeds from sale of real estate investments	255	3,631
Capital improvements to real estate investments	-5,604	-3,334
Proceeds from other investments	2,155	1,067
Investments in other investments	-1,468	-4,065
Collection of mortgage principal	288	132
Net cash used in investing activities	-18,527	-120,383
Cash flows from financing activities
Proceeds from credit facility borrowings	6,000	120,000
Payments on credit facility borrowings	-91,000	-446,000
Receipts of other long-term borrowings	689,822	594,320
Payments of other long-term borrowings	-347,883	-201,238
Payments of financing related costs	-21,318	-4,155
Receipts from dividend reinvestment plan	5,414	31,540
Payments for exercised options and restricted stock - net	-1,906	-530
Net proceeds from issuance of common stock	440,019	27,818
Dividends paid	-68,261	-61,670
Net cash provided by financing activities	610,887	60,085
Increase in cash and cash equivalents	695,654	17,758
Cash and cash equivalents at beginning of period	4,489	2,616
Cash and cash equivalents at end of period	700,143	20,374
Interest paid during the period, net of amounts capitalized	25,829	26,243
Non-cash financing activities:
Accrued dividends	$50,221

BASIS_OF_PRESENTATION_AND_SIGN

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
	Business Overview
	Omega Healthcare Investors, Inc. (“Omega” or the “Company”) has one reportable segment consisting of investments in healthcare-related real estate properties. Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”) located in the United States. Our core portfolio consists of long-term leases and mortgage agreements. All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses. Our mortgage revenue derives from fixed-rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor.
	Basis of Presentation
	The accompanying unaudited consolidated financial statements for Omega have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. We have evaluated all subsequent events through the date of the filing of this Form 10-Q. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our latest Annual Report on Form 10-K.
	Our consolidated financial statements include the accounts of (i) Omega and (ii) all direct and indirect wholly owned subsidiaries of Omega. All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.
	On April 1, 2015, Aviv REIT Inc., a Maryland corporation (“Aviv”), merged (the “Merger”) with and into a wholly owned subsidiary of Omega, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 30, 2014 (the “Merger Agreement”), by and among the Company, Aviv, OHI Healthcare Properties Holdco, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Omega (“Merger Sub”), OHI Healthcare Properties Limited Partnership, a Delaware limited partnership (“Omega OP” or the “ Operating Partnership”), and Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership (the “Aviv OP”).
	Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure (the “UPREIT Conversion”). As a result of UPREIT conversion, substantially all of the Company’s assets are held by an Operating Partnership which is a subsidiary of the Company. See Note 15 – Subsequent Events for more details.
	Recent Accounting Pronouncements
	Amendments to the Consolidation Analysis
	In February 2015, the Financial Accounting Standards Board (“FASB”) issued updated guidance that makes targeted amendments to the current consolidation accounting guidance. The update is in response to accounting complexity concerns, particularly from the asset management industry. The guidance simplifies consolidation accounting by reducing the number of approaches to consolidation, provides a scope exception to registered money market funds and similar unregistered money market funds and ends the indefinite deferral granted to investment companies from applying the variable interest entity guidance.
	The updated guidance is effective for annual and interim periods beginning after December 15, 2015. The adoption of this guidance is not expected to have a material effect on the Company’s results of operations, financial position or liquidity.
	Presentation of Debt Issuance Costs
	In April 2015, the FASB issued ASU No. 2015-03, Simplifying the Presentation of Debt Issuance Costs. This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of as a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted. The adoption of this guidance is not expected to have a material effect on the Company’s results of operations, financial position or liquidity.
	Revenue Recognition
	In May 2014, the FASB issued a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance under GAAP. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The effective date is for periods beginning after December 15, 2016. We are currently evaluating the impact, if any, the adoption of this standard will have on our consolidated financial statements.
	Accounts Receivable
	Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, are amortized as a reduction of rental revenue over the non-cancellable lease term.
	On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement. If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.
	A summary of our net receivables by type is as follows:
		March 31,			December 31,
		2015			2014
		(in thousands)
	Contractual receivables	$	4,969		$	4,799
	Effective yield interest receivables		7,352			6,232
	Straight-line receivables		148,927			143,652
	Lease inducements		15,681			13,571
	Allowance		(52	)		(78	)
	Accounts receivable – net	$	176,877		$	168,176
	We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements. We consider factors such as payment history and the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.

PROPERTIES_AND_INVESTMENTS

PROPERTIES AND INVESTMENTS	3 Months Ended
	Mar. 31, 2015
Real Estate [Abstract]
PROPERTIES AND INVESTMENTS	NOTE 2 – PROPERTIES AND INVESTMENTS
	In the ordinary course of our business activities, we periodically evaluate investment opportunities and extend credit to customers.  We also regularly engage in lease and/or loan extensions and modifications. Additionally, we actively monitor and manage our investment portfolio with the objectives of improving credit quality and increasing investment returns.  In connection with our portfolio management, we may engage in various collection and foreclosure activities.
	Leased Property
	Our leased real estate properties, represented by 421 SNFs, 22 assisted living facilities (“ALFs”) and 11 specialty facilities at March 31, 2015, are leased under provisions of single or master leases with initial terms typically ranging from 5 to 15 years, plus renewal options.  Substantially all of our leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual percentage increase over the prior year’s rent, generally 2.5%; (ii) an increase based on the change in pre-determined formulas from year to year (i.e., such as increases in the Consumer Price Index (“CPI”)); or (iii) specific dollar increases over prior years.  Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties.
	$6.8 Million New Investment in Q1 2015
	On January 28, 2015, we purchased one SNF from an unrelated third party for approximately $6.3 million in cash and leased it to an existing operator.  The purchase and sale agreement includes a provision that requires us to make an additional payment of $0.5 million to the seller if certain financial metrics of the facility are achieved.  As a result, we recorded the potential $0.5 million payment as part of the purchase price.  The 93 bed SNF, located in Texas, was added to the operator’s existing master lease with an initial annual cash yield of 9.5%.
	Pro Forma Acquisition Results
	The facilities acquired in 2015 and 2014 are included in our results of operations from the date of acquisition.  The following unaudited pro forma results of operations reflect the impact of first quarter 2015 and 2014 transactions as if they occurred on January 1, 2014.  For a list of the 2014 transactions, refer to Note 3 – Properties in our 2014 Form 10-K.  In the opinion of management, all significant necessary adjustments to reflect the effect of the acquisitions have been made.  The following pro forma information does not reflect acquisition of Aviv and is not indicative of future operations.
		Pro Forma
		Three Months Ended
		March 31,
		2015		2014
		(in thousands, except per share amounts, unaudited)
	Revenues	$	133,478	$	123,827
	Net income available to common stockholders	$	43,085	$	56,923
	Earnings per share – diluted:
	Net income available to common stockholders – as reported	$	0.32	$	0.45
	Net income available to common stockholders – pro forma	$	0.32	$	0.46
	Asset Sales, Impairments and Other
	During the three-month period ended March 31, 2015, we initiated plans to construct a new single facility with an existing operator that would consolidate and replace three existing facilities.  As a result, we recorded a total of $6.0 million in impairment charges related to three Florida SNFs to reduce their net book values to their estimated sales price.
	During the three-month period ended March 31, 2015, we reclassified one SNF in Alabama with a carrying value of approximately $4.1 million to assets held for sale.
	Mortgage Notes Receivables
	Our mortgage notes receivables relate to 14 fixed-rate mortgages on 53 SNFs and two ALFs.  The mortgage notes are secured by first mortgage liens on the borrowers’ underlying real estate and personal property.  The mortgage notes receivable relate to facilities located in five states, which are operated by five independent healthcare operating companies.  We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding loans.  As of March 31, 2015, none of our mortgages were in default or in foreclosure proceedings.  Where appropriate, the mortgaged properties are generally cross-collateralized with the master lease agreement with the same operator.
	Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method.  Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection.  When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account application of security deposits.

ASSETS_HELD_FOR_SALE

ASSETS HELD FOR SALE	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
ASSETS HELD FOR SALE	NOTE 3 – ASSETS HELD FOR SALE
		Properties Held For Sale
		Number of Properties		Net Book Value (in thousands)
	December 31, 2014 (1)		4	$	12,792
	Properties sold		—		—
	Properties added		1		4,085
	March 31, 2015 (2)		5	$	16,877
	(1)      Includes one parcel of land and three facilities.
	(2)      Included one parcel of land and four facilities.
	As mentioned above in Note 2 – Properties and Investments, in the first quarter of 2015, we reclassified one SNF in Alabama with a carrying value of approximately $4.1 million to assets held for sale.

DIRECT_FINANCING_LEASES

DIRECT FINANCING LEASES	3 Months Ended
	Mar. 31, 2015
Leases, Capital [Abstract]
DIRECT FINANCING LEASES	NOTE 4 – DIRECT FINANCING LEASES
	The components of investment in direct financing leases consist of the following:
			March 31,			December 31,
			2015			2014
			(in thousands)
	Minimum lease payments receivable		$	4,232,317		$	4,244,067
	Estimated residual values			—			—
	Less unearned income			(3,690,471	)		(3,704,835	)
	Investment in direct financing leases		$	541,846		$	539,232
	Properties subject to direct financing leases			56			56
	On November 27, 2013, we closed on an aggregate $529 million purchase/leaseback transaction in connection with the acquisition of Ark Holding Company, Inc. (“Ark Holding”) by 4 West Holdings Inc.  At closing, we acquired 55 SNFs and 1 ALF operated by Ark Holding and leased the facilities back to Ark Holding, now known as New Ark Investment Inc. (“New Ark”), pursuant to four 50-year master leases, with rental payments yielding 10.6% per annum over the term of the leases.  The purchase/leaseback transaction is being accounted for as a direct financing lease.
	The lease agreements allow the tenant the right to purchase the facilities for a bargain purchase price plus closing costs at the end of the lease term.  In addition, commencing in the 41st year of each lease, the tenant will have the right to prepay the remainder of its obligations thereunder for an amount equal to the sum of the unamortized portion of the original aggregate $529 million investment plus the net present value of the remaining payments under the lease and closing costs.  In the event the tenant exercises either of these options, we have the right to purchase the properties for fair market value at the time.
	The 56 facilities represent 5,623 licensed beds located in 12 states, predominantly in the southeastern United States. The 56 facilities are separated by region and divided amongst four cross-defaulted master leases.  The four regions include the Southeast (39 facilities), the Northwest (7 facilities), Texas (9 facilities) and Indiana (1 facility).  As of March 31, 2015, the following minimum rents are due under our direct financing leases for the next five years (in thousands):
	Year 1	Year 2	Year 3	Year 4	Year 5
	$47,000	$47,128	$47,778	$48,972	$50,197

OTHER_INVESTMENTS

OTHER INVESTMENTS	3 Months Ended
	Mar. 31, 2015
Receivables [Abstract]
OTHER INVESTMENTS	NOTE 5 – OTHER INVESTMENTS
	A summary of our other investments is as follows:
			March 31,		December 31,
			2015		2014
			(in thousands)
	Other investment notes due 2015		$	91	$	141
	Other investment notes due 2021 - 2023			17,413		16,182
	$31.5 million other investment note due 2017			23,500		23,500
	$2.5 million other investment note due 2014			—		1,640
	$6.0 million other investment note due 2015			5,439		5,439
	$1.3 million other investment note due 2017			1,300		1,300
	$0.9 million other investment note due 2015			525		750
	Notes receivable, gross(1)			48,268		48,952
	Allowance for loss on notes receivable			—		—
	Total other investments		$	48,268	$	48,952
		-1	The majority of these notes bear interest at approximately 10% annually.
	$2.5 Million Other Investment note due 2014 Payoff
	In May 2013, we entered into a $2.5 million working capital note at 6% interest rate with an existing operator.  The loan was paid off in March 2015.

CONCENTRATION_OF_RISK

CONCENTRATION OF RISK	3 Months Ended
	Mar. 31, 2015
Risks and Uncertainties [Abstract]
CONCENTRATION OF RISK	NOTE 6 – CONCENTRATION OF RISK
	As of March 31, 2015, our portfolio of real estate investments consisted of 569 healthcare facilities, located in 38 states and operated by 50 third-party operators. Our gross investment in these facilities, net of impairments and before reserve for uncollectible loans, totaled approximately $4.4 billion at March 31, 2015, with approximately 99% of our real estate investments related to long-term care facilities. Our portfolio is made up of 474 SNFs, 23 ALFs, 11 specialty facilities, fixed rate mortgages on 53 SNFs and two ALFs, and six SNFs that are closed/held-for-sale. At March 31, 2015, we also held miscellaneous investments of approximately $48.3 million, consisting primarily of secured loans to third-party operators of our facilities.
	At March 31, 2015, we had investments with one operator and/or manager that exceeded 10% of our total investments: New Ark (13%). The three states in which we had our highest concentration of investments were Florida (14%), Michigan (10%) and Ohio (9%) at March 31, 2015.
	For the three-month period ended March 31, 2015, our revenues from operations totaled $133.4 million, of which approximately $15.3 million were from New Ark (11%) and $13.8 million were from Genesis HealthCare (“Genesis”) (10%). No other operator generated more than 10% of our revenues from operations for the three-month period ended March 31, 2015.

DIVIDENDS_AND_STOCKHOLDERS_EQU

DIVIDENDS AND STOCKHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2015
Dividends [Abstract]
DIVIDENDS AND STOCKHOLDERS' EQUITY	NOTE 7 – DIVIDENDS AND STOCKHOLDERS’ EQUITY
	On April 15, 2015, our Board of Directors declared a prorated dividend of $0.18 per share of Omega’s common stock in view of the completed acquisition of Aviv, pursuant to the Merger. The per share dividend amount payable by Omega represents dividends for April 2015, at a quarterly dividend rate of $0.54 per share of common stock, representing an increase of $0.01 per share over the quarterly dividend rate for the immediately preceding quarterly period. The $0.18 dividend will be payable in cash on May 15, 2015 to stockholders of record as of the close of business on April 30, 2015.
	On March 5, 2015, the Board of Directors declared a prorated dividend of $0.36 per share of Omega’s common stock in view of the pending acquisition of Aviv, pursuant to the Merger. The per share dividend amount represented dividends for February and March 2015, at a quarterly dividend rate of $0.54 per share of common stock, representing an increase of $0.01 per share over the quarterly dividend rate for the immediately preceding quarterly period. The dividend was paid in cash on April 7, 2015 to stockholders of record as of the close of business on March 31, 2015.
	On January 14, 2015, the Board of Directors declared a common stock dividend of $0.53 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter, which was paid February 16, 2015 to common stockholders of record on February 2, 2015.
	Increase of Authorized Omega Common Stock
	On March 27, 2015, Omega amended its charter to increase the number of authorized shares of Omega capital stock from 220 million to 370 million and the number of authorized shares of Omega common stock from 200 million to 350 million.
	10.925 Million Common Stock Offering
	On February 9, 2015, we completed an underwritten public offering of 10.925 million shares of our common stock at $42.00 per share before underwriting and other offering expenses. The Company’s total net proceeds from the offering were approximately $440 million, after deducting underwriting discounts and commissions and other estimated offering expenses.
	Dividend Reinvestment and Common Stock Purchase Plan
	For the three-month period ended March 31, 2015, approximately 0.1 million shares of our common stock at an average price of $40.13 per share were issued through our Dividend Reinvestment and Common Stock Purchase Program for gross proceeds of approximately $5.4 million.

TAXES

TAXES	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
TAXES	NOTE 8 – TAXES
	So long as we qualify as a real estate investment trust (“REIT”) under the Internal Revenue Code (the “Code”), we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions. On a quarterly and annual basis, we test our compliance within the REIT taxation rules to ensure that we are in compliance with the REIT rules.
	Subject to the limitation under the REIT asset test rules, we are permitted to own up to 100% of the stock of one or more taxable REIT subsidiaries (“TRSs”). Currently, we have one TRS that is taxable as a corporation and pays federal, state and local income tax on its net income at the applicable corporate rates. As of March 31, 2015, the TRS had a net operating loss carry-forward of approximately $1.0 million. The loss carry-forward is fully reserved with a valuation allowance as of March 31, 2015.

STOCKBASED_COMPENSATION

STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 31, 2015
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
STOCK-BASED COMPENSATION	NOTE 9 – STOCK-BASED COMPENSATION
	The following is a summary of our stock-based compensation expense for the three- month periods ended March 31, 2015 and 2014, respectively:
		Three Months Ended
		March 31,
		2015				2014
		(in thousands)
	Stock-based compensation expense	$	1,610			$	2,263
	Restricted Stock and Restricted Stock Units
	Restricted stock and restricted stock units (“RSUs”) are subject to forfeiture if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. Prior to vesting, ownership of the shares/units cannot be transferred. The restricted stock has the same dividend and voting rights as our common stock. RSUs accrue dividend equivalents but have no voting rights. Restricted stock and RSUs are valued at the price of our common stock on the date of grant. We expense the cost of these awards ratably over their vesting period.
	On December 31, 2013, we granted 213,741 RSUs to employees. The RSUs vest ratably over the three year period ending December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. In December 2014, 71,247 shares of restricted stock vested and were distributed to employees.
	On January 1, 2014, we granted 122,137 RSUs to employees. The RSUs vest on December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	On March 31, 2015, we granted 123,693 RSUs to employees. The RSUs vest on December 31, 2017, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	Performance Restricted Stock Units
	Performance restricted stock units (“PRSUs”) are subject to forfeiture if the performance requirements are not achieved or if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. The PRSUs awarded in January 2011, January 2013, December 2013 and January 2014 have varying degrees of performance requirements to achieve vesting, and each PRSU award represents the right to a variable number of shares of common stock based on performance and related dividend equivalents based on dividends paid to stockholders during the applicable performance period. The vesting requirements are based on either the (i) total shareholders return (“TSR”) of Omega or (ii) Omega’s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index. We expense the cost of these awards ratably over their service period.
	Prior to vesting and distribution of shares, ownership of the PRSUs cannot be transferred. The dividends on the PRSUs accumulate and if vested are paid when the shares are distributed to the employee.
	2011 PRSU Grant (for Performance Periods 2011 through 2013)
	In January 2011, we awarded PRSUs to employees, including: (i) 279,552 multi-year absolute TSR PRSUs and (ii) 93,183 multi-year relative TSR PRSUs. On January 1, 2013, we awarded to employees 124,244 annual TSR PRSUs for the year ended December 31, 2013 (“2013 Annual TSR PRSUs”).
	2013 Annual TSR PRSUs
	The TSR goal for the 2013 Annual TSR PRSUs was achieved at the high level and 124,244 shares vested and were distributed to the employees in January 2014.
	Multi-year TSR PRSUs (for the 2011- 2013 Performance Period)
	The number of shares earned under the multi-year TSR PRSUs depended generally on the level of achievement of TSR for the three years ended December 31, 2013. In January 2014, our Board of Directors reviewed the performance and determined the performance targets were met at the high level. The multi-year TSR PRSUs vested 25% on the last day of each calendar quarter in 2014, and were distributed in 2014.
	Multi-year Relative TSR PRSUs (for the 2011- 2013 Performance Period)
	The number of shares earned under the multi-year relative TSR PRSUs depended generally on the level of achievement of TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index for the three-years ended December 31, 2013. In January 2014, our Board of Directors reviewed the performance and determined the performance targets were met at the high level. The multi-year relative TSR PRSUs vested 25% on the last day of each calendar quarter in 2014 and were distributed in 2014.
	December 31, 2013 PRSU Grant (for 2013- 2016 Performance Periods)
	In December 2013, we awarded six types of PRSUs to employees: (i) 77,371 PRSUs that vest based on TSR for the one year period starting December 31, 2013 and ending December 31, 2014 (“2014 Transition TSR PRSUs”), (ii) 77,369 PRSUs that vest based on the TSR for the two year period starting December 31, 2013 and ending December 31, 2015 (“2015 Transition TSR PRSUs”), (iii) 115,785 PRSUs that vest based on TSR for the three year period starting December 31, 2013 and ending December 31, 2016 (“2016 Transition TSR PRSUs”), (iv) 77,371 PRSUs that vest based on relative TSR for the one year period starting December 31, 2013 and ending December 31, 2014 (“2014 Transition Relative TSR PRSUs”), (v) 77,368 Transition PRSUs that vest based on relative TSR for the two year period starting December 31, 2013 and ending December 31, 2015 (“2015 Transition Relative TSR PRSUs”), and (vi) 115,781 PRSUs that vest based on relative TSR for the three year period starting December 31, 2013 and ending December 31, 2016 (“2016 Transition Relative TSR PRSUs”).
	2014 Transition TSR PRSUs
	The number of shares earned under the 2014 Transition TSR PRSUs depended generally on the level of achievement of Omega’s TSR for the period beginning December 31, 2013 and ending December 31, 2014. The 2014 Transition TSR PRSUs vested on December 31, 2014. In January 2015, our Board of Directors reviewed the performance and determined the performance targets were met at the “high” level and the shares were distributed in January 2015.
	2015 Transition TSR PRSUs
	The number of shares earned under the 2015 Transition TSR PRSUs depends generally on the level of achievement of Omega’s TSR for the period beginning December 31, 2013 and ending December 31, 2015. The 2015 Transition TSR PRSUs vest on December 31, 2015, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2016 Transition TSR PRSUs
	The number of shares earned under the 2016 Transition TSR PRSUs depends generally on the level of achievement of Omega’s TSR for the period beginning December 31, 2013 and ending December 31, 2016. The 2016 Transition TSR PRSUs vest on December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2014 Transition Relative TSR PRSUs
	The number of shares earned under the 2014 Transition Relative TSR PRSUs depended generally on the level of achievement of TSR relative to the MSCI U.S. REIT Index for the period beginning December 31, 2013 and ended December 31, 2014. The 2014 Transition Relative TSR PRSUs vested on December 31, 2014. In January 2015, our Board of Directors reviewed the performance and determined that 61,769 shares were earned. The shares were distributed in January 2015.
	2015 Transition Relative TSR PRSUs
	The number of shares earned under the 2015 Transition Relative TSR PRSUs depends generally on the level of achievement of TSR relative to MSCI U.S. REIT Index for the period beginning December 31, 2013 and ending December 31, 2015. The 2015 Transition Relative TSR PRSUs vest on December 31, 2015, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2016 Transition Relative TSR PRSUs
	The number of shares earned under the 2016 Transition Relative TSR PRSUs depends generally on the level of achievement of TSR relative to MSCI U.S. REIT Index for the period beginning December 31, 2013 and ending December 31, 2016. The 2016 Transition Relative TSR PRSUs vest on December 31, 2016, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	January 2014 PRSU Grant (for 2014- 2016 Performance Periods)
	In January 2014, we awarded two types of PRSUs to employees: (i) 154,584 PRSUs that vest based on TSR for the three year period starting January 1, 2014 and ending December 31, 2016 (“2016 TSR PRSUs”), and (ii) 154,584 PRSUs that vest based on relative TSR for the three year period starting January 1, 2014 and ending December 31, 2016 (“2016 Relative TSR PRSUs”).
	2016 TSR PRSUs
	The number of shares earned under the 2016 TSR PRSUs depends generally on the level of achievement of Omega’s TSR for the period beginning January 1, 2014 and ending December 31, 2016. The 2016 TSR PRSUs vest quarterly in 2017 in equal increments, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2016 Relative TSR PRSUs
	The number of shares earned under the 2016 Relative TSR PRSUs depends generally on the level of achievement of Omega’s TSR relative to MSCI U.S. REIT Index for the period beginning January 1, 2014 and ending December 31, 2016. The 2016 Relative TSR PRSUs vest quarterly in 2017 in equal increments, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	March 2015 PRSU and LTIP Grant (for 2015- 2017 Performance Periods)
	In March 2015, we awarded two types of awards to employees: (i) 154,716 profit interest partnership units that vest based on TSR of Omega for the three year period starting January 1, 2015 and ending December 31, 2017 (“2017 TSR LTIP Units”), and (ii) 154,716 PRSUs that vest based on relative TSR for the three year period starting January 1, 2015 and ending December 31, 2017 (“2017 Relative TSR PRSUs”).
	2017 TSR LTIPs Units
	The number of shares earned under the 2017 TSR LTIP Units depends generally on the level of achievement of Omega’s TSR for the period beginning January 1, 2015 and ending December 31, 2017. The 2017 TSR LTIPs vest quarterly in 2018 in equal increments, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	2017 Relative TSR PRSUs
	The number of shares earned under the 2017 Relative TSR PRSUs depends generally on the level of achievement of Omega’s TSR relative to MSCI U.S. REIT Index for the period beginning January 1, 2015 and ending December 31, 2017. The 2017 Relative TSR PRSUs vest quarterly in 2018 in equal increments, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	The following table summarizes our total unrecognized compensation cost as of March 31, 2015 associated with outstanding restricted stock, restricted stock units and PRSU awards to employees:
				Shares/				Grant Date		Total Compensation Cost		Weighted	Unrecognized Compensation
				Units				Average Fair		(in millions)		Average	Cost
								Value Per				Period of	(in millions)
								Unit/Share				Expense
		Grant										Recognition
		Year										(in months)
	Restricted stock units	2013			142,494			$	29.8	$	4.3	36	$	3.7
	2015 Transition TSR PRSUs	2013			77,369				7.48		0.6	24		0.2
	2016 Transition TSR PRSUs	2013			115,785				8.67		1	36		0.6
	2015 Transition Relative TSR PRSUs	2013			77,368				13.06		1	24		0.4
	2016 Transition Relative TSR PRSUs	2013			115,781				14.25		1.7	36		1
	Restricted stock units	2014			122,137				29.8		3.6	36		2.1
	2016 TSR PRSUs	2014			154,584				8.67		1.3	48		0.9
	2016 Relative TSR PRSUs	2014			154,584				14.25		2.2	48		1.5
2017 Restricted stock units	2015			123,693				40.57		5	33		5
2017 LTIPs Units	2015			154,716				14.66		2.3	45		2.3
2017 Relative TSR PRSUs	2015			154,716				22.5		3.5	45		3.5
Total				1,393,227			$	18.98	$	26.5		$	21.2
We used a Monte Carlo model to estimate the fair value for PRSUs and the LTIP Units granted to the employees.
Director Restricted Stock Grants
As of March 31, 2015, we had 37,983 shares of restricted stock outstanding to directors. The directors’ restricted shares are scheduled to vest over the next three years. As of March 31, 2015, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $0.5 million.

BORROWING_ACTIVITIES_AND_ARRAN

BORROWING ACTIVITIES AND ARRANGEMENTS	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
BORROWING ACTIVITIES AND ARRANGEMENTS	NOTE 10 – BORROWING ACTIVITIES AND ARRANGEMENTS
	Secured and Unsecured Borrowings
	The following is a summary of our long-term borrowings:
			Maturity	Rate as of		March 31,			December 31,
				March 31,		2015			2014
				2015
						(in thousands)
	Secured borrowings:
	HUD mortgages assumed June 2010 (1)		2040 - 2045	—		$	—		$	126,319
	HUD mortgages assumed October 2011 (1)		2036	4.91	%		26,457			26,658
	HUD mortgages assumed December 2011(1)		2044	3.06	%		57,116			57,416
	HUD mortgages assumed December 2012(1)		2041	4.35	%		10,146			41,061
	Total secured borrowings						93,719			251,454
	Unsecured borrowings:
	Revolving line of credit		2018	—			—			85,000
	Term loan		2019	1.68	%		200,000			200,000
							200,000			285,000
	2020 notes		2020	—			—			200,000
	2022 notes		2022	6.75	%		575,000			575,000
	2024 notes		2024	5.875	%		400,000			400,000
	2024 notes		2024	4.95	%		400,000			400,000
	2025 notes		2025	4.5	%		250,000			250,000
	2027 notes		2027	4.5	%		700,000			—
	Subordinated debt		2021	9	%		20,712			20,747
							2,345,712			1,845,747
	Discount - net						(12,055	)		(3,698	)
	Total unsecured borrowings						2,533,657			2,127,049
	Total – net					$	2,627,376		$	2,378,503
		-1	Reflects the weighted average annual contractual interest rate on the mortgages at March 31, 2015; however, excludes a 0.5% third-party administration fee.
	Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of March 31, 2015 and December 31, 2014, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings.
	Bank Credit Facilities
	On June 27, 2014, we entered into a $1.2 billion unsecured credit facility, comprised of a $1 billion senior unsecured revolving credit facility (the “Revolving Credit Facility”) and a $200 million senior unsecured term loan facility (the “Term Loan Facility” and, collectively, the “2014 Credit Facilities”).
	The Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 130 basis points, with a range of 92.5 to 170 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings, plus a facility fee based on the same ratings (initially 25 basis points, with a range of 12.5 to 30 basis points). The Revolving Credit Facility is used for acquisitions and general corporate purposes. At March 31, 2015, we had no borrowings outstanding under the Revolving Credit Facility. The Revolving Credit Facility matures on June 27, 2018, subject to a one-time option by us to extend such maturity date by one year.
	The Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. At March 31, 2015, we had $200 million in borrowings outstanding under the Term Loan Facility. The Term Loan Facility matures on June 27, 2019.
	In January 2015, we entered into an engagement letter with respect to various proposed amendments to our existing 2014 Credit Facilities. The amendments to our senior unsecured credit facility were completed on April 1, 2015. See Note 15 – Subsequent Events for more details.
	HUD Mortgage Loans Payoff
	On March 31, 2015, we paid approximately $154.3 million to retire 21 mortgage loans guaranteed by U.S. Department of Housing and Urban Development (“HUD”), totaling approximately 146.9 million. 18 loans had an all-in blended interest rate of 5.35% per annum with maturities between January 2040 and January 2045 and three loans had an all-in blended interest rate of 5.23% per annum with maturities between February 2040 and February 2045. The payoff resulted in a $2.3 million gain on the extinguishment of the debt due to the write-off of the $9.7 million unamortized debt premium recorded at the time of acquisition offset by a prepayment fee of approximately $7.4 million.
	Issuance of $700 Million of Senior Notes
	On March 18, 2015, we sold $700 million aggregate principal amount of our 4.50% Senior Notes due 2027 (the “2027 Notes”). The 2027 Notes were sold at an issue price of 98.546% of their face value before the initial purchasers’ discount. The Company’s total net proceeds from the offering, after deducting initial purchasers’ discounts and other offering expenses, were approximately $683 million. The net proceeds of the offering have or will be used for general corporate purposes, including the repayment of Aviv indebtedness on April 1, 2015 in connection with Omega’s acquisition of Aviv by merger, and repayment of future maturities on Omega’s outstanding debt.
	The 2027 Notes mature on April 1, 2027. The 2027 Notes bear an interest rate of 4.50% per annum, and are fully and unconditionally guaranteed, jointly and severally, by our existing and future subsidiaries that guarantee indebtedness for money borrowed by Omega in a principal amount at least equal to $50 million (including as of the date hereof our existing senior notes and the facilities under our credit agreement). The 2027 Notes are Omega’s unsecured senior obligations and rank equally in right of payment with all of Omega’s existing and future senior debt and is senior in right of payment to all of Omega’s existing and future subordinated debt. Omega may redeem some or all of the 2027 Notes prior to January 1, 2027 at a price equal to 100% of the principal amount thereof plus a “make-whole” premium calculated by reference to U.S. treasuries with a maturity comparable to the remaining term of the 2027 Notes, and accrued and unpaid interest, if any, to, but not including, the applicable redemption date. The 2027 Notes will be redeemable at any time on or after January 1, 2027 at a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date.
	$200 Million 7.5% Senior Notes due 2020 Redemption
	On March 13, 2015, Omega redeemed all of its outstanding 7.5% Senior Notes due 2020 (the “2020 Notes”) at a redemption price of approximately $208.7 million, consisting of 103.750% of the principal amount, plus accrued and unpaid interest on such notes to, but not including, the date of redemption.
	In connection with the redemption, during the first quarter of 2015, we recorded approximately $11.7 million redemption related costs and write-offs, including $7.5 million in prepayment fees for early redemption and $4.2 million of write-offs associated with unamortized deferred financing and discount costs. The consideration for the redemption of the 2020 Notes was funded from the net proceeds of the 10.925 million share common stock offering. See Note 7 Dividends and Stockholders’ Equity for additional details.

FINANCIAL_INSTRUMENTS

FINANCIAL INSTRUMENTS	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
FINANCIAL INSTRUMENTS	NOTE 11 – FINANCIAL INSTRUMENTS
	At March 31, 2015 and December 31, 2014, the carrying amounts and fair values of our financial instruments were as follows:
			31-Mar-15				31-Dec-14
			Carrying		Fair		Carrying		Fair
			Amount		Value		Amount		Value
	Assets:		(in thousands)
	Cash and cash equivalents		$	700,143	$	700,143	$	4,489	$	4,489
	Restricted cash			27,880		27,880		29,076		29,076
	Investment in direct financing leases			541,846		541,846		539,232		539,232
	Mortgage notes receivable – net			649,793		646,088		648,079		642,626
	Other investments – net			48,268		53,315		48,952		49,513
	Totals		$	1,967,930	$	1,969,272	$	1,269,828	$	1,264,936
	Liabilities:
	Revolving line of credit		$	—	$	—	$	85,000	$	85,000
	Term loan			200,000		200,000		200,000		200,000
	7.50% notes due 2020 – net			—		—		198,235		264,269
	6.75% notes due 2022 – net			580,237		752,996		580,410		677,851
	5.875% notes due 2024 – net			400,000		461,054		400,000		449,242
	4.95% notes due 2024 – net			394,909		418,462		394,768		410,358
	4.50% notes due 2025 – net			247,942		255,852		247,889		244,053
	4.50% notes due 2027 – net			689,857		687,048		—		—
	HUD debt			93,719		96,224		251,454		266,434
	Subordinated debt			20,712		28,620		20,747		26,434
	Totals		$	2,627,376	$	2,900,256	$	2,378,503	$	2,623,641
	Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies in our Annual Report on Form 10-K for the year ended December 31, 2014).  The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts.
	The following methods and assumptions were used in estimating fair value disclosures for financial instruments.
		·	Cash and cash equivalents and restricted cash:  The carrying amount of cash and cash equivalents and restricted cash reported in the consolidated balance sheet approximates fair value because of the short maturity of these instruments (i.e., less than 90 days) (Level 1).
		·	Mortgage notes receivable:  The fair value of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).
		·	Direct financing leases:  The fair value of the direct financing receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar leases to borrowers with similar credit ratings (Level 3).
		·	Other investments:  Other investments are primarily comprised of notes receivable.  The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3).
		·	Revolving line of credit and term loan:  The fair value of our borrowings under variable rate agreements are estimated using an expected present value technique based on expected cash flows discounted using the current market rates (Level 3).
		·	Senior notes and subordinated debt:  The fair value of our borrowings under fixed rate agreements are estimated based on open market trading activity provided by a third party (Level 2).
		·	HUD debt: The fair value of our borrowings under HUD debt agreements are estimated based on quotes obtained by HUD debt brokers (Level 2).

LITIGATION

LITIGATION	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	NOTE 12 – LITIGATION
	We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.
	As previously reported, four putative class actions were filed by purported stockholders of Aviv against Aviv, its directors, the Company and Merger Sub challenging the Merger.  The lawsuits sought injunctive relief preventing the parties from consummating the Merger, rescission of the transactions contemplated by the Merger Agreement, imposition of a constructive trust in favor of the class upon any benefits improperly received by the defendants, compensatory damages, and litigation costs including attorneys’ fees.  The four cases were transferred to the Business and Technology Case Management Program of the Circuit Court, Baltimore City, Maryland. The plaintiffs in each case amended their complaints to add allegations that the disclosures in the Form S-4 filed with the Securities and Exchange Commission on January 5, 2015 in connection with the Merger, were inadequate to allow Aviv shareholders to make an informed decision whether to approve the Merger. On January 28, 2015, the court entered a stipulated consolidation order consolidating the four lawsuits into a single proceeding styled In re Aviv REIT Inc. Stockholder Litigation, Case No. 24-C-14-006352. On February 6, 2015, (1) Aviv, the Aviv Partnership and the Aviv directors filed a motion to dismiss the consolidated complaint and (2) the Company, Merger Sub and the Omega Operating Partnership separately moved to dismiss the consolidated complaint as to them. The plaintiffs have moved to expedite the discovery period.  On March 20, 2015, the court granted the defendants’ motions to dismiss the consolidated complaint.
	In addition to these lawsuits, Omega is aware of a derivative demand letter that was delivered to the Aviv board of directors by Gary Danley (“Danley”), who subsequently filed one of the aforementioned lawsuits.  The allegations in the demand letter are substantially similar to the allegations in Danley’s complaint.
	Omega believes that these actions have no merit and intends to defend vigorously against any further attempts to prosecute these claims.  The time period for taking an appeal of the grant of the motions to dismiss has now expired and, as a result, we believe these matters are now concluded.

EARNINGS_PER_SHARE

EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2015
Net Income Available To Common Per Share
EARNINGS PER SHARE	NOTE 13 – EARNINGS PER SHARE
	The computation of basic earnings per share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the relevant period. Diluted EPS is computed using the treasury stock method, which is net income available to common stockholders divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period. Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units.
	The following tables set forth the computation of basic and diluted earnings per share:
		Three Months Ended
		March 31,
		2015		2014
		(in thousands, except per share amounts)
	Numerator:
	Net income	$	43,052	$	55,829
	Numerator for net income available to common stockholders’ per share - basic and diluted	$	43,052	$	55,829
	Denominator:
	Denominator for basic earnings per share		134,346		124,459
	Effect of dilutive securities:
	Common stock equivalents		460		363
	Denominator for diluted earnings per share		134,806		124,822
	Earnings per share – basic:
	Net income – basic	$	0.32	$	0.45
	Earnings per share – diluted:
	Net income – diluted	$	0.32	$	0.45

CONSOLIDATING_FINANCIAL_STATEM

CONSOLIDATING FINANCIAL STATEMENTS	3 Months Ended
	Mar. 31, 2015
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
CONSOLIDATING FINANCIAL STATEMENTS	NOTE 14 – CONSOLIDATING FINANCIAL STATEMENTS
	As of March 31, 2015, we had outstanding: (i) $575 million 6.75% Senior Notes due 2022, (ii) $400 million 5.875% Senior Notes due 2024, (iii) $400 million 4.95% Senior Notes due 2024, (iv) $250 million 4.5% Senior Notes due 2025 and (v) $700 million 4.5% Senior Notes due 2027, which we collectively refer to as the Senior Notes. The Senior Notes are fully and unconditionally guaranteed, jointly and severally, by each of our subsidiaries that guarantee other indebtedness of Omega or any of the subsidiary guarantors. All of our subsidiaries that guarantee the Senior Notes also guarantee the 2014 Credit Facilities. Any subsidiary that we properly designate as an “unrestricted subsidiary” under the indentures governing the Senior Notes will not provide guarantees of the Senior Notes or the 2014 Credit Facilities.
	For the three months ended March 31, 2015 and 2014, we had 47 and 52 “unrestricted subsidiaries” respectively. During the third quarter of 2014, four subsidiaries were re-designated as “restricted subsidiaries and Subsidiary Guarantors” due to the retirement of the HUD related debt on four facilities in September 2014. In October 2014, we retired HUD debt on one facility and one subsidiary was re-designated as a restricted subsidiary.
	On March 31, 2015, the Company paid off HUD debt related to 21 facilities and 32 subsidiaries will be re-designated as “restricted subsidiaries and Subsidiary Guarantors”.
	For the three months ended March 31, 2015 and 2014, the operating cash flow of the non-guarantor subsidiaries approximated net income of the non-guarantor subsidiaries, adjusted for depreciation and amortization expense and rent recorded on a straight-line basis. On September 30, 2014, we retired four HUD mortgages, $34.3 million related to the outstanding principal of the four HUD mortgages, $3.3 million related to the noncash write off of unamortized premium recorded at the time of acquisition offset by a prepayment fee of approximately $1.7 million. On October 31, 2014, we retired one HUD mortgage, $3.4 million related to the outstanding principal of the mortgage, $0.2 million related to noncash of unamortized premium offset by a prepayment fee of approximately $0.2 million.
	On March 31, 2015, we retired 21 HUD mortgages, $146.9 million related to the outstanding principal of the 21 HUD mortgages, $9.7 million related to the noncash write off of unamortized premium recorded at the time of acquisition offset by a prepayment fee of approximately $7.4 million.
	For the three months ended March 31, 2015, and 2014, the non-guarantor subsidiaries did not engage in investing or financing activities other than the principal payment of $1.0 and $1.1 million, respectively for the HUD mortgages on the facilities owned by the non-guarantor subsidiaries. As of March 31, 2015, all of the Subsidiary Guarantors of our outstanding Senior Notes and 2014 Credit Facilities, and all of our non-guarantor subsidiaries, are 100% owned by Omega. See Note 15 – Subsequent Events.
	The following summarized condensed consolidating financial information segregates the financial information of the non-guarantor subsidiaries from the financial information of Omega Healthcare Investors, Inc. and the subsidiary guarantors under the Senior Notes. The results and financial position of acquired entities are included from the dates of their respective acquisitions.
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	Unaudited
	(in thousands, except per share amounts)
		31-Mar-15
		Issuer &			Non-Guarantor			Elimination Company			Consolidated
		Subsidiary			Subsidiaries
		Guarantors
	ASSETS
	Real estate properties
	Land and buildings	$	2,837,697		$	390,286		$	-		$	3,227,983
	Less accumulated depreciation		(776,167	)		(71,073	)		-			(847,240	)
	Real estate properties – net		2,061,530			319,213			-			2,380,743
	Investment in direct financing leases		541,846			-			-			541,846
	Mortgage notes receivable – net		649,793			-			-			649,793
			3,253,169			319,213			-			3,572,382
	Other investments – net		48,268			-			-			48,268
			3,301,437			319,213			-			3,620,650
	Assets held for sale – net		16,877			-			-			16,877
	Total investments		3,318,314			319,213			-			3,637,527
	Cash and cash equivalents		700,143			-			-			700,143
	Restricted cash		7,052			20,828			-			27,880
	Accounts receivable – net		168,464			8,413			-			176,877
	Investment in affiliates		224,843			-			(224,843	)		-
	Other assets		45,506			10,087			-			55,593
	Total assets	$	4,464,322		$	358,541		$	(224,843	)	$	4,598,020
	LIABILITIES AND STOCKHOLDERS’ EQUITY
	Term loan	$	200,000		$	-		$	-		$	200,000
	Secured borrowings		-			93,719			-			93,719
	Unsecured borrowings – net		2,312,945			20,712			-			2,333,657
	Accrued expenses and other liabilities		180,424			19,267			-			199,691
	Intercompany payable		-			184,916			(184,916	)		-
	Total liabilities		2,693,369			318,614			(184,916	)		2,827,067
	Stockholders’ equity:
	Common stock		13,875			-			-			13,875
	Common stock – additional paid-in capital		2,580,248			-			-			2,580,248
	Cumulative net earnings		1,191,050			39,927			(39,927	)		1,191,050
	Cumulative dividends paid		(2,014,220	)		-			-			(2,014,220	)
	Total stockholders’ equity		1,770,953			39,927			(39,927	)		1,770,953
	Total liabilities and stockholders’ equity	$	4,464,322		$	358,541		$	(224,843	)	$	4,598,020
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	(in thousands, except per share amounts)
		31-Dec-14
		Issuer &			Non –			Elimination Company			Consolidated
		Subsidiary			Guarantor
		Guarantors			Subsidiaries
	ASSETS
	Real estate properties
	Land and buildings	$	2,834,498		$	389,287		$	—		$	3,223,785
	Less accumulated depreciation		(754,517	)		(67,195	)		—			(821,712	)
	Real estate properties – net		2,079,981			322,092			—			2,402,073
	Investment in direct financing leases		539,232			—			—			539,232
	Mortgage notes receivable – net		648,079			—			—			648,079
			3,267,292			322,092			—			3,589,384
	Other investments – net		48,952			—			—			48,952
		3,316,244			322,092			—			3,638,336
Assets held for sale – net		12,792			—			—			12,792
Total investments		3,329,036			322,092			—			3,651,128
Cash and cash equivalents		4,489			—			—			4,489
Restricted cash		7,016			22,060			—			29,076
Accounts receivable – net		160,789			7,387			—			168,176
Investment in affiliates		73,622			—			(73,622	)		—
Other assets		42,876			25,900			—			68,776
Total assets	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	85,000		$	—		$	—		$	85,000
Term loan		200,000			—			—			200,000
Secured borrowings		—			251,454			—			251,454
Unsecured borrowings – net		1,821,302			20,747			—			1,842,049
Accrued expenses and other liabilities		110,199			31,616			—			141,815
Intercompany payable		—			40,309			(40,309	)		—
Total liabilities		2,216,501			344,126			(40,309	)		2,520,318
Stockholders’ equity:
Common stock		12,761			—			—			12,761
Common stock – additional paid-in-capital		2,136,234			—			—			2,136,234
Cumulative net earnings		1,147,998			33,313			(33,313	)		1,147,998
Cumulative dividends paid		(1,895,666	)		—			—			(1,895,666	)
Total stockholders’ equity		1,401,327			33,313			(33,313	)		1,401,327
Total liabilities and stockholders’ equity	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATING STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)
	Three Months Ended March 31, 2015
	Issuer & Subsidiary Guarantors			Non –						Consolidated
				Guarantor
				Subsidiaries			Elimination
Revenue
Rental income	$	89,610		$	11,354		$	-		$	100,964
Income from direct financing leases		14,346			-			-			14,346
Mortgage interest income		16,579			-			-			16,579
Other investment income – net		1,531			-			-			1,531
Total operating revenues		122,066			11,354			-			133,420
Expenses
Depreciation and amortization		26,732			3,878			-			30,610
General and administrative		5,977			37			-			6,014
Acquisition costs		4,868			-			-			4,868
Provision for impairment on real estate properties		5,982			-			-			5,982
Provision for uncollectible mortgages, notes and accounts receivable		(2	)		-			-			(2	)
Total operating expenses		43,557			3,915			-			47,472
Income before other income and expense		78,509			7,439			-			85,948
Other income (expense):
Interest income		186			7			-			193
Interest expense		(29,235	)		(3,124	)		-			(32,359	)
Interest – amortization of deferred financing costs		(1,348	)		(5	)		-			(1,353	)
Interest – refinancing costs		(11,674	)		2,297			-			(9,377	)
Equity in earnings		6,614			-			(6,614	)		-
Total other expense		(35,457	)		(825	)		(6,614	)		(42,896	)
Income before gain (loss) on assets sold		43,052			6,614			(6,614	)		43,052
Gain (loss) on assets sold – net		-			-			-			-
Net income available to common stockholders	$	43,052		$	6,614		$	(6,614	)	$	43,052
OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATING STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)
	Three Months Ended March 31, 2014
	Issuer &			Non –						Consolidated
	Subsidiary			Guarantor
	Guarantors			Subsidiaries			Elimination
Revenue
Rental income	$	85,412		$	10,506		$	-		$	95,918
Income from direct financing leases		14,084			-			-			14,084
Mortgage interest income		9,326			-			-			9,326
Other investment income – net		1,673			-			-			1,673
Total operating revenues		110,495			10,506			-			121,001
Expenses
Depreciation and amortization		26,921			4,523			-			31,444
General and administrative		6,417			80			-			6,497
Acquisition costs		95			-			-			95
Provision for uncollectible mortgages, notes and accounts receivable		(16	)		-			-			(16	)
Total operating expenses		33,417			4,603			-			38,020
Income before other income and expense		77,078			5,903			-			82,981
Other income (expense):
Interest income		2			6			-			8
Interest expense		(23,901	)		(3,180	)		-			(27,081	)
Interest – amortization of deferred financing costs		(917	)		(5	)		-			(922	)
Interest – refinancing costs		(2,040	)		-			-			(2,040	)
Equity in earnings		2,724			-			(2,724	)		-
Total other expense		(24,132	)		(3,179	)		(2,724	)		(30,035	)
Income before gain on assets sold		52,946			2,724			(2,724	)		52,946
Gain on assets sold – net		2,883			-			-			2,883
Net income available to common stockholders	$	55,829		$	2,724		$	(2,724	)	$	55,829

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 15 – SUBSEQUENT EVENTS
	UPREIT Structure
	On April 1, 2015, the Company acquired Aviv as a result of the completion of the Merger pursuant to the Merger Agreement. See Note 1 – Basis of Presentation And Significant Accounting Policies.
	Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega completed the UPREIT Conversion, pursuant to which Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure. As a result of the UPREIT Conversion, substantially all of the Company’s assets are held by an Operating Partnership.
	In order to more fully reflect the UPREIT Conversion and related transaction, Omega, Merger Sub and Aviv OP entered into that certain Second Amended and Restated Agreement of Limited Partnership of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015 (the “Partnership Agreement”). Pursuant to the Partnership Agreement, the Company and Merger Sub are the general partners of Omega OP. As a result of the Merger, Merger Sub also is the successor general partner of Aviv OP under the terms of its partnership agreement. As of April 1, 2015, the Company is the owner of approximately 138.9 million limited partnership interests in Omega OP (“Omega OP Units”) and Aviv OP is the owner of approximately 52.9 million Omega OP Units. Each of the Omega OP Units is redeemable at the election of the Omega OP Unit holder for cash equal to the then fair market value of one share of Omega common stock, par value $0.10 per share (“Omega Common Stock”), subject to the Company’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one-for-one basis, and further subject to adjustment as set forth in the Partnership Agreement. The Company (through Merger Sub, in its capacity as the general partner of Aviv OP) plans to cause Aviv OP to make a distribution of all the Omega OP Units held by Aviv OP (or equivalent value) to all the holders of partnership interests of Aviv OP (the “Aviv OP Distribution”) in connection with the liquidation of Aviv OP. On a pro forma basis as if the Aviv OP Distribution had been completed and the Omega OP Units held by the Aviv OP distributed to the holders of Aviv OP partnership interests, Omega would directly and indirectly own approximately 182.6 million or approximately 95% of the outstanding Omega OP Units and the other holders of Aviv OP partnership units would own approximately 9.2 million or approximately 5% of the outstanding Omega OP Units as of April 1, 2015. Until the completion of the Aviv OP Distribution, distributions by Omega OP in respect of the outstanding Omega OP Units will be passed through to the limited partners of Aviv OP in respect of their limited partner interests in Aviv OP adjusted for the 0.9 exchange ratio in the merger.
	The Partnership Agreement also provides for limited partnership units structured as profits interests (“LTIP Units”), which are to be used for incentive compensation awards. When earned and vested, LTIP Units are intended to be convertible into Omega OP Units, at the election of the holder, on a one-to-one basis, subject to conditions on minimum allocation to the capital accounts of the holders of LTIP Units for federal income tax purposes.
	Amendment to Omega Credit Facilities
	On April 1, 2015, Omega entered into a First Amendment to Credit Agreement (the “First Amendment to Omega Credit Agreement”) among Omega, as borrower, certain of Omega’s subsidiaries identified in the Omega Credit Agreement (as defined below), as guarantors, a syndicate of financial institutions, as lenders (together with other lenders from time to time becoming signatory to the Omega Credit Agreement, as lenders, the “Omega Lenders”), and Bank of America, N.A., as administrative agent, which amended and restated its existing Credit Agreement, dated as of June 27, 2014 (as amended and restated pursuant to the First Amendment to Omega Credit Agreement, the “Omega Credit Agreement”). Among other things, the First Amendment to Omega Credit Agreement (i) increases the aggregate revolving commitment amount under the Revolving Credit Facility (as defined below) from $1 billion to $1.25 billion and (ii) provides for the Acquisition Term Loan Facility (as defined below).
	As a result of the First Amendment to Omega Credit Agreement, the Omega Credit Agreement now provides for a $1.25 billion senior unsecured revolving credit facility, a $200 million senior unsecured term loan facility (the “Closing Date Term Loan Facility”) and a $200 million senior unsecured incremental term loan facility (the “Acquisition Term Loan Facility” and, together with the Revolving Credit Facility and the Closing Date Term Loan Facility, collectively, the “Omega Credit Facilities”). The Revolving Credit Facility matures on June 27, 2018, subject to a one-time option for Omega to extend such maturity date for one year. Exercise of such extension option is subject to compliance with a notice requirement and other customary conditions. The Closing Date Term Loan Facility matures on June 27, 2019. The Acquisition Term Loan Facility matures on June 27, 2017, subject to Omega’s option to extend the maturity date of the Acquisition Term Loan Facility twice, the first extension until June 27, 2018 and the second extension until June 27, 2019 (such option, the “Omega Acquisition Facility Extension Option”). The Closing Date Term Loan Facility and the Acquisition Term Loan Facility may be referred to collectively herein as the “Omega Term Loan Facilities”.
	Omega OP Term Loan Facility
	On April 1, 2015, Omega OP entered into a $100 million senior unsecured term loan facility (the “Omega OP Term Loan Facility”). The Omega OP Term Loan Facility matures on June 27, 2017, subject to Omega OP’s option to extend such maturity date twice, the first extension until June 27, 2018 and the second extension until June 27, 2019 (such option, the “Omega OP Extension Option”), corresponding to the maturity date for the Acquisition Term Loan Facility and the Omega Acquisition Facility Extension Option, respectively.
	HUD Mortgage Loan Payoff
	On April 30, 2015, we paid approximately $8.6 million to retire one HUD-guaranteed mortgage loan of one of our unrestricted subsidiaries. The loan had an all-in annual interest rate of 4.85%. That unrestricted subsidiary, as well as other unrestricted subsidiary obligors on the HUD-guaranteed mortgage loans retired on March 31, 2015, are being redesignated as restricted subsidiaries and will become guarantors of the Omega Credit Facilities, the Omega OP Term Loan Facility and our outstanding senior notes. We will re-designate the subsidiary as a restricted subsidiary during the second quarter of 2015.
	Acquisition of $179 Million of Care Homes in United Kingdom
	On May 1, 2015, we closed a $179 million purchase/leaseback transaction for 23 Care Homes located in the United Kingdom and operated by Healthcare Homes Holding Limited (“Healthcare Homes”). As part of the transaction, we acquired title to the 23 Care Homes with 1,018 registered beds and leased them back to Healthcare Homes pursuant to a 12-year master lease agreement with an initial annual cash yield of 7%, and annual escalators of 2.5%. The Care Homes, comparable to US ALFs, are located throughout the East Anglia region (north of London) of the United Kingdom. Healthcare Homes is headquartered in Colchester (Essex County), England.
	April 1, 2015 RSU, PRSU and LTIP Grant (for 2015- 2017 Performance Periods)
	On April 1, 2015, we granted 39,914 RSUs to employees. The RSUs vest on December 31, 2017, subject to continued employment on the vesting date and subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company.
	On April 1, 2015, we awarded two types of awards to employees: (i) 54,151 profit interest partnership units that vest based on TSR of Omega for the three year period starting January 1, 2015 and ending December 31, 2017, and (ii) 54,151 PRSUs that vest based on relative TSR for the three year period starting January 1, 2015 and ending December 31, 2017.

BASIS_OF_PRESENTATION_AND_SIGN1

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation
	The accompanying unaudited consolidated financial statements for Omega have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. We have evaluated all subsequent events through the date of the filing of this Form 10-Q. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our latest Annual Report on Form 10-K.
	Our consolidated financial statements include the accounts of (i) Omega and (ii) all direct and indirect wholly owned subsidiaries of Omega. All inter-company accounts and transactions have been eliminated in consolidation of the financial statements.
	On April 1, 2015, Aviv REIT Inc., a Maryland corporation (“Aviv”), merged (the “Merger”) with and into a wholly owned subsidiary of Omega, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 30, 2014 (the “Merger Agreement”), by and among the Company, Aviv, OHI Healthcare Properties Holdco, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Omega (“Merger Sub”), OHI Healthcare Properties Limited Partnership, a Delaware limited partnership (“Omega OP” or the “Operating Partnership”), and Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership (the “Aviv OP”).
	Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure (the “UPREIT Conversion”). As a result of UPREIT conversion, substantially all of the Company’s assets are held by an Operating Partnership which is a subsidiary of the Company. See Note 15 – Subsequent Events for more details.
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	Amendments to the Consolidation Analysis
	In February 2015, the Financial Accounting Standards Board (“FASB”) issued updated guidance that makes targeted amendments to the current consolidation accounting guidance. The update is in response to accounting complexity concerns, particularly from the asset management industry. The guidance simplifies consolidation accounting by reducing the number of approaches to consolidation, provides a scope exception to registered money market funds and similar unregistered money market funds and ends the indefinite deferral granted to investment companies from applying the variable interest entity guidance.
	The updated guidance is effective for annual and interim periods beginning after December 15, 2015. The adoption of this guidance is not expected to have a material effect on the Company’s results of operations, financial position or liquidity.
	Presentation of Debt Issuance Costs
	In April 2015, the FASB issued ASU No. 2015-03, Simplifying the Presentation of Debt Issuance Costs. This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of as a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted. The adoption of this guidance is not expected to have a material effect on the Company’s results of operations, financial position or liquidity.
	Revenue Recognition
	In May 2014, the FASB issued a comprehensive new revenue recognition standard that will supersede nearly all existing revenue recognition guidance under GAAP. The standard’s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The effective date is for periods beginning after December 15, 2016. We are currently evaluating the impact, if any, the adoption of this standard will have on our consolidated financial statements.
Accounts Receivable	Accounts Receivable
	Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, are amortized as a reduction of rental revenue over the non-cancellable lease term.
	On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement. If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis or existence of lease inducements, we generally provide an allowance for straight-line accounts receivable and/or the lease inducements when certain conditions or indicators of adverse collectability are present.
	A summary of our net receivables by type is as follows:
		March 31,			December 31,
		2015			2014
		(in thousands)
	Contractual receivables	$	4,969		$	4,799
	Effective yield interest receivables		7,352			6,232
	Straight-line receivables		148,927			143,652
	Lease inducements		15,681			13,571
	Allowance		(52	)		(78	)
	Accounts receivable – net	$	176,877		$	168,176
	We continuously evaluate the payment history and financial strength of our operators and have historically established allowance reserves for straight-line rent adjustments for operators that do not meet our requirements. We consider factors such as payment history and the operator’s financial condition as well as current and future anticipated operating trends when evaluating whether to establish allowance reserves.

BASIS_OF_PRESENTATION_AND_SIGN2

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Schedule of summary of net receivables		March 31,			December 31,
		2015			2014
		(in thousands)
	Contractual receivables	$	4,969		$	4,799
	Effective yield interest receivables		7,352			6,232
	Straight-line receivables		148,927			143,652
	Lease inducements		15,681			13,571
	Allowance		(52	)		(78	)
	Accounts receivable – net	$	176,877		$	168,176

PROPERTIES_AND_INVESTMENTS_Tab

PROPERTIES AND INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2015
Real Estate [Abstract]
Schedule of unaudited pro forma results of business acquisition		Pro Forma
		Three Months Ended
		March 31,
		2015		2014
		(in thousands, except per share amounts, unaudited)
	Revenues	$	133,478	$	123,827
	Net income available to common stockholders	$	43,085	$	56,923
	Earnings per share – diluted:
	Net income available to common stockholders – as reported	$	0.32	$	0.45
	Net income available to common stockholders – pro forma	$	0.32	$	0.46

ASSETS_HELD_FOR_SALE_Tables

ASSETS HELD FOR SALE (Tables)	3 Months Ended
	Mar. 31, 2015
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Schedule of properties held-for-sale		Properties Held For Sale
		Number of Properties		Net Book Value (in thousands)
	December 31, 2014 (1)		4	$	12,792
	Properties sold		—		—
	Properties added		1		4,085
	March 31, 2015 (2)		5	$	16,877
	(1)      Includes one parcel of land and three facilities.
	(2)      Included one parcel of land and four facilities.

DIRECT_FINANCING_LEASES_Tables

DIRECT FINANCING LEASES (Tables)	3 Months Ended
	Mar. 31, 2015
Leases, Capital [Abstract]
Schedule of components of investment in direct financing leases			March 31,			December 31,
			2015			2014
			(in thousands)
	Minimum lease payments receivable		$	4,232,317		$	4,244,067
	Estimated residual values			—			—
	Less unearned income			(3,690,471	)		(3,704,835	)
	Investment in direct financing leases		$	541,846		$	539,232
	Properties subject to direct financing leases			56			56
Schedule of minimum rents due under direct financing lease for the next five years	Year 1	Year 2	Year 3	Year 4	Year 5
	$47,000	$47,128	$47,778	$48,972	$50,197

OTHER_INVESTMENTS_Tables

OTHER INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2015
Receivables [Abstract]
Schedule of other investments			March 31,		December 31,
			2015		2014
			(in thousands)
	Other investment notes due 2015		$	91	$	141
	Other investment notes due 2021 - 2023			17,413		16,182
	$31.5 million other investment note due 2017			23,500		23,500
	$2.5 million other investment note due 2014			—		1,640
	$6.0 million other investment note due 2015			5,439		5,439
	$1.3 million other investment note due 2017			1,300		1,300
	$0.9 million other investment note due 2015			525		750
	Notes receivable, gross(1)			48,268		48,952
	Allowance for loss on notes receivable			—		—
	Total other investments		$	48,268	$	48,952
		-1	The majority of these notes bear interest at approximately 10% annually.

STOCKBASED_COMPENSATION_Tables

STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Schedule of stock-based compensation expense		Three Months Ended March 31,
		2015				2014
		(in thousands)
	Stock-based compensation expense	$	1,610			$	2,263
Schedule of unrecognized compensation cost associated with outstanding restricted stock and PRSU awards
				Shares/				Grant Date		Total Compensation Cost		Weighted	Unrecognized Compensation
				Units				Average Fair		(in millions)		Average	Cost
								Value Per				Period of	(in millions)
								Unit/Share				Expense
		Grant										Recognition
		Year										(in months)
	Restricted stock units	2013			142,494			$	29.8	$	4.3	36	$	3.7
	2015 Transition TSR PRSUs	2013			77,369				7.48		0.6	24		0.2
	2016 Transition TSR PRSUs	2013			115,785				8.67		1	36		0.6
	2015 Transition Relative TSR PRSUs	2013			77,368				13.06		1	24		0.4
	2016 Transition Relative TSR PRSUs	2013			115,781				14.25		1.7	36		1
	Restricted stock units	2014			122,137				29.8		3.6	36		2.1
	2016 TSR PRSUs	2014			154,584				8.67		1.3	48		0.9
	2016 Relative TSR PRSUs	2014			154,584				14.25		2.2	48		1.5
	2017 Restricted stock units	2015			123,693				40.57		5	33		5
	2017 LTIPs Units	2015			154,716				14.66		2.3	45		2.3
	2017 Relative TSR PRSUs	2015			154,716				22.5		3.5	45		3.5
	Total				1,393,227			$	18.98	$	26.5		$	21.2

BORROWING_ACTIVITIES_AND_ARRAN1

BORROWING ACTIVITIES AND ARRANGEMENTS (Tables)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Schedule of long-term borrowings
			Maturity	Rate as of		March 31,			December 31,
				March 31,		2015			2014
				2015
						(in thousands)
	Secured borrowings:
	HUD mortgages assumed June 2010 (1)		2040 - 2045	—		$	—		$	126,319
	HUD mortgages assumed October 2011 (1)		2036	4.91	%		26,457			26,658
	HUD mortgages assumed December 2011(1)		2044	3.06	%		57,116			57,416
	HUD mortgages assumed December 2012(1)		2041	4.35	%		10,146			41,061
	Total secured borrowings						93,719			251,454
	Unsecured borrowings:
	Revolving line of credit		2018	—			—			85,000
	Term loan		2019	1.68	%		200,000			200,000
							200,000			285,000
	2020 notes		2020	—			—			200,000
	2022 notes		2022	6.75	%		575,000			575,000
	2024 notes		2024	5.875	%		400,000			400,000
	2024 notes		2024	4.95	%		400,000			400,000
	2025 notes		2025	4.5	%		250,000			250,000
	2027 notes		2027	4.5	%		700,000			—
	Subordinated debt		2021	9	%		20,712			20,747
							2,345,712			1,845,747
	Discount - net						(12,055	)		(3,698	)
	Total unsecured borrowings						2,533,657			2,127,049
	Total – net					$	2,627,376		$	2,378,503
		-1	Reflects the weighted average annual contractual interest rate on the mortgages at March 31, 2015; however, excludes a 0.5% third-party administration fee.

FINANCIAL_INSTRUMENTS_Tables

FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Schedule of the carrying amounts and fair values of financial instruments		31-Mar-15				31-Dec-14
		Carrying		Fair		Carrying		Fair
		Amount		Value		Amount		Value
	Assets:	(in thousands)
	Cash and cash equivalents	$	700,143	$	700,143	$	4,489	$	4,489
	Restricted cash		27,880		27,880		29,076		29,076
	Investment in direct financing leases		541,846		541,846		539,232		539,232
	Mortgage notes receivable – net		649,793		646,088		648,079		642,626
	Other investments – net		48,268		53,315		48,952		49,513
	Totals	$	1,967,930	$	1,969,272	$	1,269,828	$	1,264,936
	Liabilities:
	Revolving line of credit	$	—	$	—	$	85,000	$	85,000
	Term loan		200,000		200,000		200,000		200,000
	7.50% notes due 2020 – net		—		—		198,235		264,269
	6.75% notes due 2022 – net		580,237		752,996		580,410		677,851
	5.875% notes due 2024 – net		400,000		461,054		400,000		449,242
	4.95% notes due 2024 – net		394,909		418,462		394,768		410,358
	4.50% notes due 2025 – net		247,942		255,852		247,889		244,053
	4.50% notes due 2027 – net		689,857		687,048		—		—
	HUD debt		93,719		96,224		251,454		266,434
	Subordinated debt		20,712		28,620		20,747		26,434
	Totals	$	2,627,376	$	2,900,256	$	2,378,503	$	2,623,641

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2015
Net Income Available To Common Per Share
Schedule of computation of basic and diluted earnings per share		Three Months Ended
		March 31,
		2015		2014
		(in thousands, except per share amounts)
	Numerator:
	Net income	$	43,052	$	55,829
	Numerator for net income available to common stockholders’ per share - basic and diluted	$	43,052	$	55,829
	Denominator:
	Denominator for basic earnings per share		134,346		124,459
	Effect of dilutive securities:
	Common stock equivalents		460		363
	Denominator for diluted earnings per share		134,806		124,822
	Earnings per share – basic:
	Net income – basic	$	0.32	$	0.45
	Earnings per share – diluted:
	Net income – diluted	$	0.32	$	0.45

CONSOLIDATING_FINANCIAL_STATEM1

CONSOLIDATING FINANCIAL STATEMENTS (Tables)	3 Months Ended
	Mar. 31, 2015
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
Schedule of consolidating balance sheets
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	Unaudited
	(in thousands, except per share amounts)
		31-Mar-15
		Issuer &			Non-Guarantor			Elimination Company			Consolidated
		Subsidiary			Subsidiaries
		Guarantors
	ASSETS
	Real estate properties
	Land and buildings	$	2,837,697		$	390,286		$	-		$	3,227,983
	Less accumulated depreciation		(776,167	)		(71,073	)		-			(847,240	)
	Real estate properties – net		2,061,530			319,213			-			2,380,743
	Investment in direct financing leases		541,846			-			-			541,846
	Mortgage notes receivable – net		649,793			-			-			649,793
			3,253,169			319,213			-			3,572,382
	Other investments – net		48,268			-			-			48,268
			3,301,437			319,213			-			3,620,650
	Assets held for sale – net		16,877			-			-			16,877
	Total investments		3,318,314			319,213			-			3,637,527
	Cash and cash equivalents		700,143			-			-			700,143
	Restricted cash		7,052			20,828			-			27,880
	Accounts receivable – net		168,464			8,413			-			176,877
	Investment in affiliates		224,843			-			(224,843	)		-
	Other assets		45,506			10,087			-			55,593
	Total assets	$	4,464,322		$	358,541		$	(224,843	)	$	4,598,020
	LIABILITIES AND STOCKHOLDERS’ EQUITY
	Term loan	$	200,000		$	-		$	-		$	200,000
	Secured borrowings		-			93,719			-			93,719
	Unsecured borrowings – net		2,312,945			20,712			-			2,333,657
	Accrued expenses and other liabilities		180,424			19,267			-			199,691
	Intercompany payable		-			184,916			(184,916	)		-
	Total liabilities		2,693,369			318,614			(184,916	)		2,827,067
	Stockholders’ equity:
	Common stock		13,875			-			-			13,875
	Common stock – additional paid-in capital		2,580,248			-			-			2,580,248
	Cumulative net earnings		1,191,050			39,927			(39,927	)		1,191,050
	Cumulative dividends paid		(2,014,220	)		-			-			(2,014,220	)
	Total stockholders’ equity		1,770,953			39,927			(39,927	)		1,770,953
	Total liabilities and stockholders’ equity	$	4,464,322		$	358,541		$	(224,843	)	$	4,598,020
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING BALANCE SHEETS
	(in thousands, except per share amounts)
		31-Dec-14
		Issuer &			Non –			Elimination Company			Consolidated
		Subsidiary			Guarantor
		Guarantors			Subsidiaries
	ASSETS
	Real estate properties
	Land and buildings	$	2,834,498		$	389,287		$	—		$	3,223,785
	Less accumulated depreciation		(754,517	)		(67,195	)		—			(821,712	)
	Real estate properties – net		2,079,981			322,092			—			2,402,073
	Investment in direct financing leases		539,232			—			—			539,232
	Mortgage notes receivable – net		648,079			—			—			648,079
			3,267,292			322,092			—			3,589,384
	Other investments – net		48,952			—			—			48,952
			3,316,244			322,092			—			3,638,336
	Assets held for sale – net		12,792			—			—			12,792
	Total investments		3,329,036			322,092			—			3,651,128
	Cash and cash equivalents		4,489			—			—			4,489
	Restricted cash		7,016			22,060			—			29,076
	Accounts receivable – net		160,789			7,387			—			168,176
	Investment in affiliates		73,622			—			(73,622	)		—
Other assets		42,876			25,900			—			68,776
Total assets	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
LIABILITIES AND STOCKHOLDERS’ EQUITY
Revolving line of credit	$	85,000		$	—		$	—		$	85,000
Term loan		200,000			—			—			200,000
Secured borrowings		—			251,454			—			251,454
Unsecured borrowings – net		1,821,302			20,747			—			1,842,049
Accrued expenses and other liabilities		110,199			31,616			—			141,815
Intercompany payable		—			40,309			(40,309	)		—
Total liabilities		2,216,501			344,126			(40,309	)		2,520,318
Stockholders’ equity:
Common stock		12,761			—			—			12,761
Common stock – additional paid-in-capital		2,136,234			—			—			2,136,234
Cumulative net earnings		1,147,998			33,313			(33,313	)		1,147,998
Cumulative dividends paid		(1,895,666	)		—			—			(1,895,666	)
Total stockholders’ equity		1,401,327			33,313			(33,313	)		1,401,327
Total liabilities and stockholders’ equity	$	3,617,828		$	377,439		$	(73,622	)	$	3,921,645
Schedule of consolidating statement of operations	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING STATEMENTS OF OPERATIONS
	Unaudited
	(in thousands, except per share amounts)
		Three Months Ended March 31, 2015
		Issuer & Subsidiary Guarantors			Non –						Consolidated
					Guarantor
					Subsidiaries			Elimination
	Revenue
	Rental income	$	89,610		$	11,354		$	-		$	100,964
	Income from direct financing leases		14,346			-			-			14,346
	Mortgage interest income		16,579			-			-			16,579
	Other investment income – net		1,531			-			-			1,531
	Total operating revenues		122,066			11,354			-			133,420
	Expenses
	Depreciation and amortization		26,732			3,878			-			30,610
	General and administrative		5,977			37			-			6,014
	Acquisition costs		4,868			-			-			4,868
	Provision for impairment on real estate properties		5,982			-			-			5,982
	Provision for uncollectible mortgages, notes and accounts receivable		(2	)		-			-			(2	)
	Total operating expenses		43,557			3,915			-			47,472
	Income before other income and expense		78,509			7,439			-			85,948
	Other income (expense):
	Interest income		186			7			-			193
	Interest expense		(29,235	)		(3,124	)		-			(32,359	)
	Interest – amortization of deferred financing costs		(1,348	)		(5	)		-			(1,353	)
	Interest – refinancing costs		(11,674	)		2,297			-			(9,377	)
	Equity in earnings		6,614			-			(6,614	)		-
	Total other expense		(35,457	)		(825	)		(6,614	)		(42,896	)
	Income before gain (loss) on assets sold		43,052			6,614			(6,614	)		43,052
	Gain (loss) on assets sold – net		-			-			-			-
	Net income available to common stockholders	$	43,052		$	6,614		$	(6,614	)	$	43,052
	OMEGA HEALTHCARE INVESTORS, INC.
	CONSOLIDATING STATEMENTS OF OPERATIONS
	Unaudited
	(in thousands, except per share amounts)
		Three Months Ended March 31, 2014
		Issuer &			Non –						Consolidated
		Subsidiary			Guarantor
		Guarantors			Subsidiaries			Elimination
	Revenue
	Rental income	$	85,412		$	10,506		$	-		$	95,918
	Income from direct financing leases		14,084			-			-			14,084
	Mortgage interest income		9,326			-			-			9,326
	Other investment income – net		1,673			-			-			1,673
	Total operating revenues		110,495			10,506			-			121,001
	Expenses
	Depreciation and amortization		26,921			4,523			-			31,444
	General and administrative		6,417			80			-			6,497
	Acquisition costs		95			-			-			95
	Provision for uncollectible mortgages, notes and accounts receivable		(16	)		-			-			(16	)
	Total operating expenses		33,417			4,603			-			38,020
	Income before other income and expense		77,078			5,903			-			82,981
	Other income (expense):
	Interest income		2			6			-			8
	Interest expense		(23,901	)		(3,180	)		-			(27,081	)
	Interest – amortization of deferred financing costs		(917	)		(5	)		-			(922	)
	Interest – refinancing costs		(2,040	)		-			-			(2,040	)
	Equity in earnings		2,724			-			(2,724	)		-
	Total other expense		(24,132	)		(3,179	)		(2,724	)		(30,035	)
	Income before gain on assets sold		52,946			2,724			(2,724	)		52,946
	Gain on assets sold – net		2,883			-			-			2,883
	Net income available to common stockholders	$	55,829		$	2,724		$	(2,724	)	$	55,829

BASIS_OF_PRESENTATION_AND_SIGN3

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Contractual receivables	$4,969	$4,799
Effective yield interest receivables	7,352	6,232
Straight-line receivables	148,927	143,652
Lease inducements	15,681	13,571
Allowance	-52	-78
Accounts receivable - net	$176,877	$168,176

BASIS_OF_PRESENTATION_AND_SIGN4

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail)	3 Months Ended
	Mar. 31, 2015
	Segment
Accounting Policies [Abstract]
Number of reportable segment	1

PROPERTIES_AND_INVESTMENTS_una

PROPERTIES AND INVESTMENTS (unaudited) (Detail) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Earnings per share - diluted:
Net income available to common stockholders - as reported	$0.32	$0.45
Pro forma
Proforma Information [Line Items]
Revenues	$133,478	$123,827
Net income available to common stockholders	$43,085	$56,923
Earnings per share - diluted:
Net income available to common stockholders - as reported	$0.32	$0.45
Net income available to common stockholders - pro forma	$0.32	$0.46

PROPERTIES_AND_INVESTMENTS_Lea

PROPERTIES AND INVESTMENTS - Leased Property (Narrative) (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015
Leased Properties [Line Items]
Increase in the specific annual percentage over the prior year's rent	2.50%
Property available for operating lease | Minimum
Leased Properties [Line Items]
Lease term	5 years
Property available for operating lease | Maximum
Leased Properties [Line Items]
Lease term	15 years
SNF's
Leased Properties [Line Items]
Number of leased real estate properties	421
Cash paid for acquisition	6.3
Potential payment as part of the purchase price	0.5
SNF's | Texas
Leased Properties [Line Items]
Number of operating beds	93
Initial cash yield	9.50%
ALFs
Leased Properties [Line Items]
Number of leased real estate properties	22
Specialty facilities
Leased Properties [Line Items]
Number of leased real estate properties	11

PROPERTIES_AND_INVESTMENTS_Ass

PROPERTIES AND INVESTMENTS - Assets Sold or Held for Sale (Narrative) (Detail 1) (USD $)	3 Months Ended
	Mar. 31, 2015		Dec. 31, 2014
	Facility
Real Estate Properties [Line Items]
Net book value of held-for-sale	$16,877,000	[1]	$12,792,000	[2]
SNF's | Florida
Real Estate Properties [Line Items]
Number of facilities to be replaced	3
Impairment charge	6,000,000
Number of facilities	3
SNF's | Alabama
Real Estate Properties [Line Items]
Number of held for sale facilities	1
Net book value of held-for-sale	$4,100,000
[1]	Included one parcel of land and four facilities.
[2]	Includes one parcel of land and three facilities.

PROPERTIES_AND_INVESTMENTS_Mor

PROPERTIES AND INVESTMENTS - Mortgage Notes Receivables (Narrative) (Detail 2)	Mar. 31, 2015
	State
	Facility
	Operator
Real Estate Properties [Line Items]
Number of facilities owned	569
Number of states	38
Number of operators	50
Mortgage Receivable
Real Estate Properties [Line Items]
Number of fixed-rate mortgages	14
Number of states	5
Number of operators	5
Mortgage Receivable | SNF's
Real Estate Properties [Line Items]
Number of facilities owned	53
Mortgage Receivable | ALFs
Real Estate Properties [Line Items]
Number of facilities owned	2

ASSETS_HELD_FOR_SALE_Details

ASSETS HELD FOR SALE (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
	Facility
Number Of Properties
31-Dec-14	4	[1]
Properties sold
Properties added	1
31-Mar-15	5	[2]
Net Book Value
31-Dec-14	$12,792	[1]
Properties sold
Properties added	4,085
31-Mar-15	$16,877	[2]
[1]	Includes one parcel of land and three facilities.
[2]	Included one parcel of land and four facilities.

ASSETS_HELD_FOR_SALE_Narrative

ASSETS HELD FOR SALE (Narrative) (Detail) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014
	Parcel		Parcel
	Facility		Facility
Real Estate Properties [Line Items]
Number of parcel of land classified as held for sale	1		1
Number of facilities held for sale	4		3
Real Estate Held-for-sale	$16,877	[1]	$12,792	[2]
SNF's | ALABAMA
Real Estate Properties [Line Items]
Number of held for sale facilities	1
Real Estate Held-for-sale	$4,100
[1]	Included one parcel of land and four facilities.
[2]	Includes one parcel of land and three facilities.

DIRECT_FINANCING_LEASES_Detail

DIRECT FINANCING LEASES (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified	Property	Property
Leases, Capital [Abstract]
Minimum lease payments receivable	$4,232,317	$4,244,067
Estimated residual values
Less unearned income	-3,690,471	-3,704,835
Investment in direct financing leases	$541,846	$539,232
Properties subject to direct financing leases	56	56

DIRECT_FINANCING_LEASES_Detail1

DIRECT FINANCING LEASES (Detail 1) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Leases, Capital [Abstract]
Year 1	$47,000
Year 2	47,128
Year 3	47,778
Year 4	48,972
Year 5	$50,197

DIRECT_FINANCING_LEASES_Narrat

DIRECT FINANCING LEASES (Narrative) (Detail) (USD $)	1 Months Ended
In Millions, unless otherwise specified	Nov. 27, 2013	Mar. 31, 2015
	Bed	Facility
	Lease	State
	Facility
	State
Capital Leased Assets [Line Items]
Number of facilities owned		569
Number of states		38
Ark Holding Company Inc
Capital Leased Assets [Line Items]
Cash paid for acquisition	$529
Number of lease	4
Number of facilities owned	56
Master lease term	50 years
Interest on lease per annum	10.60%
Number of licensed beds	5,623
Number of states	12
Ark Holding Company Inc | Southeast
Capital Leased Assets [Line Items]
Number of facilities owned	39
Ark Holding Company Inc | Northwest
Capital Leased Assets [Line Items]
Number of facilities owned	7
Ark Holding Company Inc | Texas
Capital Leased Assets [Line Items]
Number of facilities owned	9
Ark Holding Company Inc | Indiana
Capital Leased Assets [Line Items]
Number of facilities owned	1
SNF's | Ark Holding Company Inc | Direct financing leases
Capital Leased Assets [Line Items]
Number of facilities owned	55
ALFs | Ark Holding Company Inc | Direct financing leases
Capital Leased Assets [Line Items]
Number of facilities owned	1

OTHER_INVESTMENTS_Details

OTHER INVESTMENTS (Details) (USD $)	Mar. 31, 2015		Dec. 31, 2014
In Thousands, unless otherwise specified
Schedule of Investments [Line Items]
Notes receivable, gross	$48,268	[1]	$48,952	[1]
Allowance for loss on notes receivable
Total other investments	48,268		48,952
Other investment note due 2015
Schedule of Investments [Line Items]
Notes receivable, gross	91		141
Other investment notes due 2021 - 2023
Schedule of Investments [Line Items]
Notes receivable, gross	17,413		16,182
$31.5 million other investment note due 2017
Schedule of Investments [Line Items]
Notes receivable, gross	23,500		23,500
$2.5 million other investment note due 2014
Schedule of Investments [Line Items]
Notes receivable, gross			1,640
$6.0 million other investment note due 2015
Schedule of Investments [Line Items]
Notes receivable, gross	5,439		5,439
$1.3 million other investment note due 2017
Schedule of Investments [Line Items]
Notes receivable, gross	1,300		1,300
$0.9 million other investment note due 2015
Schedule of Investments [Line Items]
Notes receivable, gross	$525		$750
[1]	The majority of these notes bear interest at approximately 10% annually.

OTHER_INVESTMENTS_Narrative_De

OTHER INVESTMENTS (Narrative) (Detail) ($2.5 million other investment note due 2014, USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
$2.5 million other investment note due 2014
Short-term Debt [Line Items]
Loan amount	$2,500
Notes issued, interest rate	6.00%

CONCENTRATION_OF_RISK_Narrativ

CONCENTRATION OF RISK (Narrative) (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
	Facility
	Operator
	State
Concentration Risk [Line Items]
Number of facilities owned	569
Number of states	38
Number of operators	50
Gross investment in facilities, net of impairments and before reserve for uncollectible loans	$4,400,000,000
Percentage share of real estate investments related to long-term care facilities	99.00%
Miscellaneous investments, net	48,268,000		48,952,000
Concentration percent of operated facilities for separate disclosure	10.00%
Concentration number of operated facilities	1
Revenues from operations	133,420,000	121,001,000
Revenues from operations, percentage	10.00%
Florida
Concentration Risk [Line Items]
Concentration percent by state	14.00%
Michigan
Concentration Risk [Line Items]
Concentration percent by state	10.00%
Ohio
Concentration Risk [Line Items]
Concentration percent by state	9.00%
New Ark Investment, Inc.
Concentration Risk [Line Items]
Revenues from operations	15,300,000
Revenues from operations, percentage	11.00%
Operated, concentration percent	13.00%
Genesis Healthcare
Concentration Risk [Line Items]
Revenues from operations	$13,800,000
Revenues from operations, percentage	10.00%
SNF's
Concentration Risk [Line Items]
Number of facilities owned	474
Number of facilities held-for-sale/closed	6
Number of facilities under fixed rate mortgage loan	53
ALFs
Concentration Risk [Line Items]
Number of facilities owned	23
Number of facilities under fixed rate mortgage loan	2
Specialty facilities
Concentration Risk [Line Items]
Number of facilities owned	11

DIVIDENDS_AND_STOCKHOLDERS_EQU1

DIVIDENDS AND STOCKHOLDERS' EQUITY (Narrative) (Detail) (USD $)	3 Months Ended	0 Months Ended
	Mar. 31, 2015	Apr. 15, 2015	Jan. 14, 2015	Mar. 05, 2015
Dividends [Line Items]
Cash dividends paid on common stock	$0.89
Dividend Paid
Dividends [Line Items]
Cash dividends paid on common stock	$0.36
Subsequent Event | Dividend Declared
Dividends [Line Items]
Common stock dividend payable, per share		$0.54	$0.53
Nature of common stock dividend payable		Quarterly	Quarterly
Increase in quarterly common dividend, per share		$0.01	$0.01
Dividends declared, date of declaration			14-Jan-15
Dividends declared, date of payment			16-Feb-15
Dividends declared, date of record			2-Feb-15
Aviv REIT, Inc | Dividend Declared
Dividends [Line Items]
Common stock dividend payable, per share				$0.36
Dividends declared, date of declaration				5-Mar-15
Dividends declared, date of payment				7-Apr-15
Dividends declared, date of record				31-Mar-15
Aviv REIT, Inc | Subsequent Event | Dividend Declared
Dividends [Line Items]
Common stock dividend payable, per share		$0.18
Dividends declared, date of declaration		15-Apr-15
Dividends declared, date of payment		15-May-15
Dividends declared, date of record		30-Apr-15

DIVIDENDS_AND_STOCKHOLDERS_EQU2

DIVIDENDS AND STOCKHOLDERS' EQUITY (Narrative) (Detail 1) (USD $)	0 Months Ended	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Feb. 09, 2015	Mar. 31, 2015	Mar. 27, 2015	Mar. 26, 2015	Dec. 31, 2014
Dividends [Abstract]
Capital stock, shares authorized			370,000,000	220,000,000
Common stock, shares authorized		350,000,000	350,000,000	200,000,000	200,000,000
Shares of common stock issued in an underwritten public offering	10,925,000	10,925,000
Common stock, price per share	$42	$40.32
Proceeds from shares of common stock issued in an underwritten public offering	$440,000	$440,019
Shares issued under Dividend Reinvestment and Common Stock Purchase Program		135,000
Dividend Reinvestment and Common Stock Purchase Program, price per share		$40.13
Net proceeds from shares issued under Dividend Reinvestment and Common Stock Purchase Program		$5,414

TAXES_Narrative_Detail

TAXES (Narrative) (Detail) (USD $)	Mar. 31, 2015
In Millions, unless otherwise specified
Income Tax Disclosure [Abstract]
Permitted ownership of a taxable REIT subsidiary ("TRS"), maximum percentage	100.00%
Net operating loss carry-forward	$1

STOCKBASED_COMPENSATION_Detail

STOCK-BASED COMPENSATION (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Stock-based compensation expense	$1,610	$2,263

STOCKBASED_COMPENSATION_Detail1

STOCK-BASED COMPENSATION (Detail 1) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015	Jan. 31, 2014	Dec. 31, 2013	Jan. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units	1,393,227
Grant Date Average Fair Value Per Unit/ Share	$18.98
Total Compensation Cost	$26.50
Unrecognized Compensation Cost	21.2
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	142,494	122,137	213,741
Grant Date Average Fair Value Per Unit/ Share	$29.80
Total Compensation Cost	4.3
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	3.7
Restricted stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2014
Grant Date Average Fair Value Per Unit/ Share	$29.80
Total Compensation Cost	3.6
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	2.1
Performance restricted stock units | Multi-year TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units				279,552
Performance restricted stock units | Multi-year Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units				93,183
Performance restricted stock units | 2015 Transition TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	77,369		77,369
Grant Date Average Fair Value Per Unit/ Share	$7.48
Total Compensation Cost	0.6
Weighted Average Period of Expense Recognition	24 months
Unrecognized Compensation Cost	0.2
Performance restricted stock units | 2016 Transition TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	115,785		115,785
Grant Date Average Fair Value Per Unit/ Share	$8.67
Total Compensation Cost	1
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	0.6
Performance restricted stock units | 2015 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	77,368		77,368
Grant Date Average Fair Value Per Unit/ Share	$13.06
Total Compensation Cost	1
Weighted Average Period of Expense Recognition	24 months
Unrecognized Compensation Cost	0.4
Performance restricted stock units | 2016 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2013
Shares/Units	115,781		115,781
Grant Date Average Fair Value Per Unit/ Share	$14.25
Total Compensation Cost	1.7
Weighted Average Period of Expense Recognition	36 months
Unrecognized Compensation Cost	1
Performance restricted stock units | 2016 TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2014
Shares/Units	154,584	154,584
Grant Date Average Fair Value Per Unit/ Share	$8.67
Total Compensation Cost	1.3
Weighted Average Period of Expense Recognition	48 months
Unrecognized Compensation Cost	0.9
Performance restricted stock units | 2016 Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2014
Shares/Units	154,584	154,584
Grant Date Average Fair Value Per Unit/ Share	$14.25
Total Compensation Cost	2.2
Weighted Average Period of Expense Recognition	48 months
Unrecognized Compensation Cost	1.5
Performance restricted stock units | 2017 LTIPs Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2015
Shares/Units	154,716
Grant Date Average Fair Value Per Unit/ Share	$14.66
Total Compensation Cost	2.3
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	2.3
Performance restricted stock units | 2017 Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2015
Shares/Units	154,716
Grant Date Average Fair Value Per Unit/ Share	$22.50
Total Compensation Cost	3.5
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	3.5
2017 Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2015
Shares/Units	123,693
Grant Date Average Fair Value Per Unit/ Share	$40.57
Total Compensation Cost	5
Weighted Average Period of Expense Recognition	33 months
Unrecognized Compensation Cost	$5

STOCKBASED_COMPENSATION_Narrat

STOCK-BASED COMPENSATION (Narrative) (Detail)	1 Months Ended	12 Months Ended	1 Months Ended		3 Months Ended	12 Months Ended	1 Months Ended
	Dec. 31, 2013	Dec. 31, 2014	Jan. 31, 2015	Jan. 31, 2014	Mar. 31, 2015	Dec. 31, 2013	Jan. 31, 2014	Jan. 31, 2011
				Type_Award	Type_Award
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted					1,393,227
Restricted stock units ("RSUs")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	213,741			122,137	142,494	213,741	122,137
Vesting period, years	3 years
Shares of stock vested		71,247
Restricted stock units ("RSUs") | December 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted					123,693
Restricted stock units ("RSUs") | 2014 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of stock vested			61,769
Performance restricted stock units ("PRSUs")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Method used to estimate the fair value for PRSUs					Monte Carlo model
Number of types of share based awards	6			2	2
Performance restricted stock units ("PRSUs") | Multi-year TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted								279,552
Performance restricted stock units ("PRSUs") | Multi-year TSR PRSUs | Vesting on March 31, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Multi-year TSR PRSUs | Vesting on June 30, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Multi-year TSR PRSUs | Vesting on September 30, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Multi-year TSR PRSUs | Vesting on December 31, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Multi-year Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted								93,183
Performance restricted stock units ("PRSUs") | Multi-year Relative TSR PRSUs | Vesting on March 31, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Multi-year Relative TSR PRSUs | Vesting on June 30, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Multi-year Relative TSR PRSUs | Vesting on September 30, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Multi-year Relative TSR PRSUs | Vesting on December 31, 2014 | Awards granted in January 1, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock awards, vesting percent					25.00%
Performance restricted stock units ("PRSUs") | Annual TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	124,244					124,244
Shares of stock vested						124,244
Performance restricted stock units ("PRSUs") | 2014 Transition TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period, years	1 year
Shares of stock vested					77,371
Performance restricted stock units ("PRSUs") | 2015 Transition TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	77,369				77,369	77,369
Vesting period, years	2 years
Performance restricted stock units ("PRSUs") | 2016 Transition TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	115,785				115,785	115,785
Vesting period, years	3 years
Performance restricted stock units ("PRSUs") | 2014 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period, years	1 year
Performance restricted stock units ("PRSUs") | 2015 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	77,368				77,368	77,368
Vesting period, years	2 years
Performance restricted stock units ("PRSUs") | 2016 Transition Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	115,781				115,781	115,781
Vesting period, years	3 years
Performance restricted stock units ("PRSUs") | 2016 TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted				154,584	154,584		154,584
Vesting period, years							3 years
Performance restricted stock units ("PRSUs") | 2016 Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted				154,584	154,584		154,584
Vesting period, years							3 years
Performance restricted stock units ("PRSUs") | 2017 LTIPs PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted					154,716
Performance restricted stock units ("PRSUs") | 2017 Relative PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted					154,716

STOCKBASED_COMPENSATION_Narrat1

STOCK-BASED COMPENSATION (Narrative) (Detail 1) (USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock outstanding	1,393,227
Unrecognized compensation Cost	$21.20
Restricted stock | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of restricted stock outstanding	37,983
Vesting period, years	3 years
Unrecognized compensation Cost	$0.50

BORROWING_ACTIVITIES_AND_ARRAN2

BORROWING ACTIVITIES AND ARRANGEMENTS - Long-term borrowings (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015		Dec. 31, 2014		Mar. 13, 2015	Mar. 18, 2015
Secured borrowings:
HUD debt	$93,719		$251,454
Unsecured borrowings:
Revolving line of credit			85,000
Term loan	200,000		200,000
Revolving line of credit including term loan	200,000		285,000
Total - net	2,627,376		2,378,503
Secured borrowings | HUD mortgages assumed June 2010
Debt Instrument [Line Items]
Maturity	2040 - 2045	[1]
Rate		[1]
Secured borrowings:
Long-term borrowing amount, secured borrowings		[1]	126,319	[1]
Secured borrowings | HUD mortgages assumed October 2011
Debt Instrument [Line Items]
Maturity	2036	[1]
Rate	4.91%	[1]
Secured borrowings:
Long-term borrowing amount, secured borrowings	26,457	[1]	26,658	[1]
Secured borrowings | HUD mortgages assumed December 2011
Debt Instrument [Line Items]
Maturity	2044	[1]
Rate	3.06%	[1]
Secured borrowings:
Long-term borrowing amount, secured borrowings	57,116	[1]	57,416	[1]
Secured borrowings | HUD mortgages assumed December 2012
Debt Instrument [Line Items]
Maturity	2041	[1]
Rate	4.35%	[1]
Secured borrowings:
Long-term borrowing amount, secured borrowings	10,146	[1]	41,061	[1]
Unsecured borrowings
Unsecured borrowings:
Unsecured borrowing	2,345,712		1,845,747
Discount - net	-12,055		-3,698
Total unsecured borrowings	2,533,657		2,127,049
Unsecured borrowings | Revolving line of credit
Debt Instrument [Line Items]
Maturity	2018
Rate
Unsecured borrowings:
Revolving line of credit			85,000
Unsecured borrowings | Term loan
Debt Instrument [Line Items]
Maturity	2019
Rate	1.68%
Unsecured borrowings:
Term loan	200,000		200,000
Unsecured borrowings | 2020 notes
Debt Instrument [Line Items]
Maturity	2020
Rate					7.50%
Unsecured borrowings:
Senior notes outstanding
Unsecured borrowings | 2022 notes
Debt Instrument [Line Items]
Maturity	2022
Rate	6.75%
Unsecured borrowings:
Senior notes outstanding	575,000		575,000
Unsecured borrowings | 2024 notes
Debt Instrument [Line Items]
Maturity	2024
Rate	5.88%
Unsecured borrowings:
Senior notes outstanding	400,000		400,000
Unsecured borrowings | 2024 notes
Debt Instrument [Line Items]
Maturity	2024
Rate	4.95%
Unsecured borrowings:
Senior notes outstanding	400,000		400,000
Unsecured borrowings | 2025 notes
Debt Instrument [Line Items]
Maturity	2025
Rate	4.50%
Unsecured borrowings:
Senior notes outstanding	250,000		250,000
Unsecured borrowings | 2027 notes
Debt Instrument [Line Items]
Maturity	2027
Rate	4.50%					4.50%
Unsecured borrowings:
Senior notes outstanding	700,000					700,000
Unsecured borrowings | Subordinated debt
Debt Instrument [Line Items]
Maturity	2021
Rate	9.00%
Unsecured borrowings:
Subordinated debt	$20,712		$20,747
[1]	Reflects the weighted average annual contractual interest rate on the mortgages at March 31, 2015; however, excludes a 0.5% third-party administration fee.

BORROWING_ACTIVITIES_AND_ARRAN3

BORROWING ACTIVITIES AND ARRANGEMENTS - Long-term borrowings (Parentheticals) (Detail)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Excluded percentage of third party administration fee	0.50%

BORROWING_ACTIVITIES_AND_ARRAN4

BORROWING ACTIVITIES AND ARRANGEMENTS - Long-term borrowings (Detail) - Unsecured Borrowings (Narrative) (Detail) (USD $)	3 Months Ended	1 Months Ended
	Mar. 31, 2015	Mar. 18, 2015	Dec. 31, 2014	Jun. 27, 2014
Borrowing Arrangements [Line Items]
Term loan	200,000,000		$200,000,000
Revolving line of credit			85,000,000
Unsecured borrowings
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity				1,200,000,000
Unsecured borrowings | Senior unsecured revolving credit facility
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity				1,000,000,000
Pricing of credit facility at LIBOR plus an applicable percentage	1.30%
Credit facility, description of variable rate basis	The Revolving Credit Facility is priced at LIBOR plus an applicable percentage (beginning at 130 basis points, with a range of 92.5 to 170 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings,
Facility fee, basis spread on variable rate	0.25%
Facility fee, description of variable rate basis	facility fee based on the same ratings (initially 25 basis points, with a range of 12.5 to 30 basis points)
Debt maturity date	27-Jun-18
Unsecured borrowings | Senior unsecured revolving credit facility | Minimum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	0.09%
Facility fee, basis spread on variable rate	0.13%
Unsecured borrowings | Senior unsecured revolving credit facility | Maximum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.70%
Facility fee, basis spread on variable rate	0.30%
Unsecured borrowings | Term Loan Facility
Borrowing Arrangements [Line Items]
Credit facility, borrowing capacity				200,000,000
Term loan	200,000,000
Pricing of credit facility at LIBOR plus an applicable percentage	1.50%
Credit facility, description of variable rate basis	The Term Loan Facility is also priced at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings.
Debt maturity date	27-Jun-19
Unsecured borrowings | Term Loan Facility | Minimum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.00%
Unsecured borrowings | Term Loan Facility | Maximum
Borrowing Arrangements [Line Items]
Pricing of credit facility at LIBOR plus an applicable percentage	1.95%
Unsecured borrowings | 2024 notes
Borrowing Arrangements [Line Items]
Current Rate	4.95%
Senior notes, principal amount	400,000,000		400,000,000
Unsecured borrowings | 2025 notes
Borrowing Arrangements [Line Items]
Current Rate	4.50%
Senior notes, principal amount	250,000,000		250,000,000
Unsecured borrowings | 2027 notes
Borrowing Arrangements [Line Items]
Current Rate	4.50%	4.50%
Senior notes, principal amount	700,000,000	700,000,000
Redemption price percentage specified on principal amount		100.00%
Debt maturity date		1-Apr-27
Debt instrument, issuance price, percentage of principal amount issued		98.55%
Net proceeds from issuance of debt, after deducting initial purchasers' discounts		683,000,000
Minimum borrowing required to be fully guaranteed		$50,000,000

BORROWING_ACTIVITIES_AND_ARRAN5

BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail 1) (HUD, USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015
	Mortgage
Debt Instrument [Line Items]
Number of HUD mortgages	21
Payment to retire HUD mortgages	$154.30
Total HUD mortgage loans principal payoff	146.9
Gain on extinguishment of the debt	2.3
Write-off of premium recorded at time of acquisition	9.7
Prepayment fees	$7.40
Hud interest rate 5.35%
Debt Instrument [Line Items]
Number of mortgage loans	18
Notes issued, interest rate	5.35%
Lease expiration period	January 2040 and January 2045
Hud interest rate 5.23%
Debt Instrument [Line Items]
Number of mortgage loans	3
Notes issued, interest rate	5.23%
Lease expiration period	February 2040 and February 2045

BORROWING_ACTIVITIES_AND_ARRAN6

BORROWING ACTIVITIES AND ARRANGEMENTS (Narrative) (Detail 2) (Unsecured borrowings, 7.50% notes due 2020, USD $)	0 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Mar. 13, 2015	Mar. 31, 2015
Unsecured borrowings | 7.50% notes due 2020
Debt Instrument [Line Items]
Current Rate	7.50%
Redemption price, percentage	103.75%
Redemption price	$208.70
Redemption related costs and write-offs		11.7
Redemption prepayment fee		7.5
Write off deferred financing and discount costs		$4.20

FINANCIAL_INSTRUMENTS_Detail

FINANCIAL INSTRUMENTS (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets:
Cash and cash equivalents	$700,143	$4,489	$20,374	$2,616
Restricted cash	27,880	29,076
Investment in direct financing leases	541,846	539,232
Mortgage notes receivable - net	649,793	648,079
Other investments - net	48,268	48,952
Liabilities:
Revolving line of credit		85,000
Term loan	200,000	200,000
HUD debt	93,719	251,454
Carrying Amount
Assets:
Cash and cash equivalents	700,143	4,489
Restricted cash	27,880	29,076
Investment in direct financing leases	541,846	539,232
Mortgage notes receivable - net	649,793	648,079
Other investments - net	48,268	48,952
Totals	1,967,930	1,269,828
Liabilities:
Revolving line of credit		85,000
Term loan	200,000	200,000
HUD debt	93,719	251,454
Subordinated debt	20,712	20,747
Totals	2,627,376	2,378,503
Carrying Amount | 7.50% notes due 2020
Liabilities:
Notes Payable		198,235
Carrying Amount | 6.75% notes due 2022
Liabilities:
Notes Payable	580,237	580,410
Carrying Amount | 5.875% notes due 2024
Liabilities:
Notes Payable	400,000	400,000
Carrying Amount | 4.95% notes due 2024
Liabilities:
Notes Payable	394,909	394,768
Carrying Amount | 4.50% notes due 2025
Liabilities:
Notes Payable	247,942	247,889
Carrying Amount | 4.50% notes due 2027
Liabilities:
Notes Payable	689,857
Fair Value
Assets:
Cash and cash equivalents	700,143	4,489
Restricted cash	27,880	29,076
Investment in direct financing leases	541,846	539,232
Mortgage notes receivable - net	646,088	642,626
Other investments - net	53,315	49,513
Totals	1,969,272	1,264,936
Liabilities:
Revolving line of credit		85,000
Term loan	200,000	200,000
HUD debt	96,224	266,434
Subordinated debt	28,620	26,434
Totals	2,900,256	2,623,641
Fair Value | 7.50% notes due 2020
Liabilities:
Notes Payable		264,269
Fair Value | 6.75% notes due 2022
Liabilities:
Notes Payable	752,996	677,851
Fair Value | 5.875% notes due 2024
Liabilities:
Notes Payable	461,054	449,242
Fair Value | 4.95% notes due 2024
Liabilities:
Notes Payable	418,462	410,358
Fair Value | 4.50% notes due 2025
Liabilities:
Notes Payable	255,852	244,053
Fair Value | 4.50% notes due 2027
Liabilities:
Notes Payable	$687,048

FINANCIAL_INSTRUMENTS_Parenthe

FINANCIAL INSTRUMENTS (Parentheticals) (Detail)	Mar. 31, 2015
7.50% notes due 2020
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes issued, interest rate	7.50%
6.75% notes due 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes issued, interest rate	6.75%
5.875% notes due 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes issued, interest rate	5.88%
4.95% notes due 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes issued, interest rate	4.95%
4.50% notes due 2025
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes issued, interest rate	4.50%
4.50% notes due 2027
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes issued, interest rate	4.50%

LITIGATION_Details

LITIGATION (Details)	3 Months Ended
	Mar. 31, 2015
	Class_actions
Commitments and Contingencies Disclosure [Abstract]
Number of class actions filed by purported stockholders	4

EARNINGS_PER_SHARE_Detail

EARNINGS PER SHARE (Detail) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Numerator:
Net income	$43,052	$55,829
Numerator for net income available to common stockholders' per share - basic and diluted	$43,052	$55,829
Denominator:
Denominator for basic earnings per share	134,346,000	124,459,000
Effect of dilutive securities:
Common stock equivalents	460,000	363,000
Denominator for diluted earnings per share	134,806,000	124,822,000
Earnings per share - basic:
Net income - basic (in dollars per share)	$0.32	$0.45
Earnings per share - diluted:
Net income - diluted (in dollars per share)	$0.32	$0.45

CONSOLIDATING_FINANCIAL_STATEM2

CONSOLIDATING FINANCIAL STATEMENTS (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real estate properties
Land and buildings	$3,227,983	$3,223,785
Less accumulated depreciation	-847,240	-821,712
Real estate properties - net	2,380,743	2,402,073
Investment in direct financing leases	541,846	539,232
Mortgage notes receivable - net	649,793	648,079
Real estate properties, total	3,572,382	3,589,384
Other investments - net	48,268	48,952
Total investments held, continuing operations	3,620,650	3,638,336
Assets held for sale - net	16,877	12,792
Total investments	3,637,527	3,651,128
Cash and cash equivalents	700,143	4,489	20,374	2,616
Restricted cash	27,880	29,076
Accounts receivable - net	176,877	168,176
Investment in affiliates
Other assets	55,593	68,776
Total assets	4,598,020	3,921,645
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit		85,000
Term loan	200,000	200,000
Secured borrowings	93,719	251,454
Unsecured borrowings - net	2,333,657	1,842,049
Accrued expenses and other liabilities	199,691	141,815
Intercompany payable
Total liabilities	2,827,067	2,520,318
Stockholders' equity:
Common stock	13,875	12,761
Common stock - additional paid-in-capital	2,580,248	2,136,234
Cumulative net earnings	1,191,050	1,147,998
Cumulative dividends paid	-2,014,220	-1,895,666
Total stockholders' equity	1,770,953	1,401,327
Total liabilities and stockholders' equity	4,598,020	3,921,645
Issuer & Subsidiary Guarantors
Real estate properties
Land and buildings	2,837,697	2,834,498
Less accumulated depreciation	-776,167	-754,517
Real estate properties - net	2,061,530	2,079,981
Investment in direct financing leases	541,846	539,232
Mortgage notes receivable - net	649,793	648,079
Real estate properties, total	3,253,169	3,267,292
Other investments - net	48,268	48,952
Total investments held, continuing operations	3,301,437	3,316,244
Assets held for sale - net	16,877	12,792
Total investments	3,318,314	3,329,036
Cash and cash equivalents	700,143	4,489
Restricted cash	7,052	7,016
Accounts receivable - net	168,464	160,789
Investment in affiliates	224,843	73,622
Other assets	45,506	42,876
Total assets	4,464,322	3,617,828
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit		85,000
Term loan	200,000	200,000
Secured borrowings
Unsecured borrowings - net	2,312,945	1,821,302
Accrued expenses and other liabilities	180,424	110,199
Intercompany payable
Total liabilities	2,693,369	2,216,501
Stockholders' equity:
Common stock	13,875	12,761
Common stock - additional paid-in-capital	2,580,248	2,136,234
Cumulative net earnings	1,191,050	1,147,998
Cumulative dividends paid	-2,014,220	-1,895,666
Total stockholders' equity	1,770,953	1,401,327
Total liabilities and stockholders' equity	4,464,322	3,617,828
Non-Guarantor Subsidiaries
Real estate properties
Land and buildings	390,286	389,287
Less accumulated depreciation	-71,073	-67,195
Real estate properties - net	319,213	322,092
Investment in direct financing leases
Mortgage notes receivable - net
Real estate properties, total	319,213	322,092
Other investments - net
Total investments held, continuing operations	319,213	322,092
Assets held for sale - net
Total investments	319,213	322,092
Cash and cash equivalents
Restricted cash	20,828	22,060
Accounts receivable - net	8,413	7,387
Investment in affiliates
Other assets	10,087	25,900
Total assets	358,541	377,439
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit
Term loan
Secured borrowings	93,719	251,454
Unsecured borrowings - net	20,712	20,747
Accrued expenses and other liabilities	19,267	31,616
Intercompany payable	184,916	40,309
Total liabilities	318,614	344,126
Stockholders' equity:
Common stock
Common stock - additional paid-in-capital
Cumulative net earnings	39,927	33,313
Cumulative dividends paid
Total stockholders' equity	39,927	33,313
Total liabilities and stockholders' equity	358,541	377,439
Elimination Company
Real estate properties
Land and buildings
Less accumulated depreciation
Real estate properties - net
Investment in direct financing leases
Mortgage notes receivable - net
Real estate properties, total
Other investments - net
Total investments held, continuing operations
Assets held for sale - net
Total investments
Cash and cash equivalents
Restricted cash
Accounts receivable - net
Investment in affiliates	-224,843	-73,622
Other assets
Total assets	-224,843	-73,622
LIABILITIES AND STOCKHOLDERS' EQUITY
Revolving line of credit
Term loan
Secured borrowings
Unsecured borrowings - net
Accrued expenses and other liabilities
Intercompany payable	-184,916	-40,309
Total liabilities	-184,916	-40,309
Stockholders' equity:
Common stock
Common stock - additional paid-in-capital
Cumulative net earnings	-39,927	-33,313
Cumulative dividends paid
Total stockholders' equity	-39,927	-33,313
Total liabilities and stockholders' equity	($224,843)	($73,622)

CONSOLIDATING_FINANCIAL_STATEM3

CONSOLIDATING FINANCIAL STATEMENTS (Detail 1) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenue
Rental income	$100,964	$95,918
Income from direct financing leases	14,346	14,084
Mortgage interest income	16,579	9,326
Other investment income - net	1,531	1,673
Total operating revenues	133,420	121,001
Expenses
Depreciation and amortization	30,610	31,444
General and administrative	6,014	6,497
Acquisition costs	4,868	95
Provision for impairment on real estate properties	5,982
Provisions for uncollectible mortgages, notes and accounts receivable	-2	-16
Total operating expenses	47,472	38,020
Income before other income and expense	85,948	82,981
Other income (expense):
Interest income	193	8
Interest expense	-32,359	-27,081
Interest - amortization of deferred financing costs	-1,353	-922
Interest - refinancing costs	-9,377	-2,040
Equity in earnings
Total other expense	-42,896	-30,035
Income before gain (loss) on assets sold	43,052	52,946
Gain on assets sold - net		2,883
Net income available to common stockholders	43,052	55,829
Issuer & Subsidiary Guarantors
Revenue
Rental income	89,610	85,412
Income from direct financing leases	14,346	14,084
Mortgage interest income	16,579	9,326
Other investment income - net	1,531	1,673
Total operating revenues	122,066	110,495
Expenses
Depreciation and amortization	26,732	26,921
General and administrative	5,977	6,417
Acquisition costs	4,868	95
Provision for impairment on real estate properties	5,982
Provisions for uncollectible mortgages, notes and accounts receivable	-2	-16
Total operating expenses	43,557	33,417
Income before other income and expense	78,509	77,078
Other income (expense):
Interest income	186	2
Interest expense	-29,235	-23,901
Interest - amortization of deferred financing costs	-1,348	-917
Interest - refinancing costs	-11,674	-2,040
Equity in earnings	6,614	2,724
Total other expense	-35,457	-24,132
Income before gain (loss) on assets sold	43,052	52,946
Gain on assets sold - net		2,883
Net income available to common stockholders	43,052	55,829
Non-Guarantor Subsidiaries
Revenue
Rental income	11,354	10,506
Income from direct financing leases
Mortgage interest income
Other investment income - net
Total operating revenues	11,354	10,506
Expenses
Depreciation and amortization	3,878	4,523
General and administrative	37	80
Acquisition costs
Provision for impairment on real estate properties
Provisions for uncollectible mortgages, notes and accounts receivable
Total operating expenses	3,915	4,603
Income before other income and expense	7,439	5,903
Other income (expense):
Interest income	7	6
Interest expense	-3,124	-3,180
Interest - amortization of deferred financing costs	-5	-5
Interest - refinancing costs	2,297
Equity in earnings
Total other expense	-825	-3,179
Income before gain (loss) on assets sold	6,614	2,724
Gain on assets sold - net
Net income available to common stockholders	6,614	2,724
Elimination Company
Revenue
Rental income
Income from direct financing leases
Mortgage interest income
Other investment income - net
Total operating revenues
Expenses
Depreciation and amortization
General and administrative
Acquisition costs
Provision for impairment on real estate properties
Provisions for uncollectible mortgages, notes and accounts receivable
Total operating expenses
Income before other income and expense
Other income (expense):
Interest income
Interest expense
Interest - amortization of deferred financing costs
Interest - refinancing costs
Equity in earnings	-6,614	-2,724
Total other expense	-6,614	-2,724
Income before gain (loss) on assets sold	-6,614	-2,724
Gain on assets sold - net
Net income available to common stockholders	($6,614)	($2,724)

CONSOLIDATING_FINANCIAL_STATEM4

CONSOLIDATING FINANCIAL STATEMENTS (Narrative) (Detail) (USD $)	3 Months Ended	1 Months Ended	3 Months Ended		1 Months Ended
	Mar. 31, 2015	Sep. 30, 2014	Sep. 30, 2014	Mar. 31, 2014	Oct. 31, 2014	Dec. 31, 2014
	Facility	Subsidiary	Mortgage		Subsidiary
	Subsidiary		Subsidiary
7.50% notes due 2020
Condensed Financial Statements, Captions [Line Items]
Rate on senior notes	7.50%
6.75% notes due 2022
Condensed Financial Statements, Captions [Line Items]
Rate on senior notes	6.75%
5.875% notes due 2024
Condensed Financial Statements, Captions [Line Items]
Rate on senior notes	5.88%
4.95% notes due 2024
Condensed Financial Statements, Captions [Line Items]
Rate on senior notes	4.95%
HUD debt | Non-guarantor subsidiaries
Condensed Financial Statements, Captions [Line Items]
Number of subsidiaries acquired and designated as unrestricted	47			52
Number of subsidiaries acquired and designated as restricted	32			1
Number of facilities related to retirement of Hud related mortgages	21
Hud Debt | Non-guarantor subsidiaries
Condensed Financial Statements, Captions [Line Items]
Number of subsidiaries acquired and designated as restricted		4	4
Principal payment for mortgage	1,000,000	$34,300,000		$1,100,000
Ownership percent of the subsidiary guarantors (in percent)	100.00%
Number of facilities related to retirement of Hud related mortgages			4
Noncash write off of unamortized premium		3,300,000
Prepayment fees		1,700,000
HUD Mortgage Debt | Non-guarantor subsidiaries
Condensed Financial Statements, Captions [Line Items]
Number of subsidiaries acquired and designated as restricted					1
Principal payment for mortgage	146,900,000				3,400,000
Number of facilities related to retirement of Hud related mortgages	21				1
Noncash write off of unamortized premium	9,700,000				200,000
Prepayment fees	7,400,000				200,000
4.50% notes due 2025
Condensed Financial Statements, Captions [Line Items]
Rate on senior notes	4.50%
Unsecured borrowings | 7.50% notes due 2020
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount
Unsecured borrowings | 6.75% notes due 2022
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	575,000,000					575,000,000
Rate on senior notes	6.75%
Unsecured borrowings | 5.875% notes due 2024
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	400,000,000					400,000,000
Rate on senior notes	5.88%
Unsecured borrowings | 4.95% notes due 2024
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	400,000,000					400,000,000
Rate on senior notes	4.95%
Unsecured borrowings | 4.50% notes due 2025
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	250,000,000					250,000,000
Rate on senior notes	4.50%
Unsecured borrowings | 4.5% Notes due 2027
Condensed Financial Statements, Captions [Line Items]
Senior notes, principal amount	700,000,000
Rate on senior notes	4.50%

SUBSEQUENT_EVENTS_Narrative_De

SUBSEQUENT EVENTS (Narrative) (Detail) (Subsequent Event, Omega OP Units, USD $)	Apr. 01, 2015
In Millions, except Per Share data, unless otherwise specified
Subsequent Event [Line Items]
Limited partnership interests owned	138.9
Limited partnership units, Redeemable, Par value per share	$0.10
Limited partnership interests owned on pro forma basis	182.6
Percentage of limited partnership interests owned on pro forma basis	95.00%
Aviv Operating Partnership
Subsequent Event [Line Items]
Limited partnership interests owned	52.9
Limited partnership units, Redeemable, Par value per share	$0.10
Limited partnership interests owned on pro forma basis	9.2
Percentage of limited partnership interests owned on pro forma basis	5.00%
Exchange ratio	0.9

SUBSEQUENT_EVENTS_Narrative_De1

SUBSEQUENT EVENTS (Narrative) (Detail 1) (USD $)	3 Months Ended	1 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Apr. 30, 2015	Apr. 01, 2015
	Mortgage	Mortgage
HUD
Subsequent Event [Line Items]
Number of HUD mortgages	21
Payment to retire HUD mortgages	$154.30
Subsequent Event | HUD
Subsequent Event [Line Items]
Number of HUD mortgages		1
Payment to retire HUD mortgages		8.6
Annual interest rate		4.85%
Subsequent Event | Senior unsecured revolving credit facility | Omega Credit Agreement
Subsequent Event [Line Items]
Credit facility, borrowing capacity			1,000
Subsequent Event | Senior unsecured revolving credit facility | First Amendment to Omega Credit Agreement
Subsequent Event [Line Items]
Credit facility, borrowing capacity			1,250
Subsequent Event | Closing Date Term Loan Facility | First Amendment to Omega Credit Agreement
Subsequent Event [Line Items]
Term loan, borrowing capacity			200
Subsequent Event | Acquisition Term Loan Facility | First Amendment to Omega Credit Agreement
Subsequent Event [Line Items]
Term loan, borrowing capacity			200
Subsequent Event | Omega OP Term Loan Facility
Subsequent Event [Line Items]
Term loan, borrowing capacity			$100

SUBSEQUENT_EVENTS_Narrative_De2

SUBSEQUENT EVENTS (Narrative) (Detail 2) (USD $)	1 Months Ended	0 Months Ended	1 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Apr. 01, 2015	31-May-15	Mar. 31, 2015	Jan. 31, 2014	1-May-15
						Care_Home
						Bed
Subsequent Event [Line Items]
Number of shares granted				1,393,227
Restricted stock units ("RSUs")
Subsequent Event [Line Items]
Number of shares granted	213,741			142,494	122,137
Vesting period, years	3 years
Subsequent Event | Restricted stock units ("RSUs")
Subsequent Event [Line Items]
Number of shares granted		39,914
Subsequent Event | Performance restricted stock units ("PRSUs")
Subsequent Event [Line Items]
Number of shares granted		54,151
Vesting period, years		3 years
Subsequent Event | Healthcare Homes
Subsequent Event [Line Items]
Purchase leaseback transaction amount						$179
Number of care homes located in the United Kingdom						23
Number of registered beds						1,018
Master lease agreement term			12 years
Percentage of initial annual cash yield						7.00%
Percentage of annual escalators						2.50%